var title_f29_49_30480="Extrafollicular penetration in pseudofolliculitis barbae";
var content_f29_49_30480=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Extrafollicular penetration in pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reentry of the hair&nbsp;into the skin occurs after the hair has exited the follicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30480=[""].join("\n");
var outline_f29_49_30480=null;
var title_f29_49_30481="Raynaud phenomenon";
var content_f29_49_30481=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Raynaud phenomenon (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30481/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30481/contributors\" id=\"au470\">",
"       Fredrick M Wigley, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30481/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30481/contributors\" id=\"se2035\">",
"       John S Axford, DSc, MD, FRCP, FRCPCH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30481/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30481/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?29/49/30481?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The Raynaud phenomenon (RP) is a condition in which some of the body&rsquo;s blood vessels (most commonly those in the fingers and toes) constrict in an exaggerated way in response to cold or emotional stress.",
"    </p>",
"    <p>",
"     Normally, blood vessels supplying the skin constrict or narrow in response to cold temperatures. This reaction, called &ldquo;vasoconstriction,&rdquo; decreases blood flow to the skin, which helps to minimize heat loss and to preserve a normal internal or &ldquo;core&rdquo; temperature. In warm temperatures, these same blood vessels dilate, allowing heat to leave the body. The blood vessels in the skin that react to temperature changes are called thermoregulatory vessels. These specialized blood vessels are controlled by the sympathetic nervous system, the same system that reacts when we are nervous or upset emotionally. This explains why both cold and emotional stress can trigger cold fingers and hands.",
"    </p>",
"    <p>",
"     In people with Raynaud phenomenon (RP), the mechanisms that control vasoconstriction are thought to be altered or defective. The vessels constrict in an exaggerated way in response to cold and emotional or physical stress. The severe constriction restricts blood flow to the affected areas and causes the skin to change to a white color, when there is virtually no blood flow. The skin may then become a purplish-blue color (called acrocyanosis), caused by low oxygen levels in the blood as the oxygen is lost during the slow moving flow of blood through the skin. When the vessel recovers, it dilates, allowing blood flow to resume; the skin may blush, becoming very pink or red.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      RAYNAUD PHENOMENON RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     It is estimated that RP affects 3 to 5 percent of the general population.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Primary disease",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients who have Raynaud phenomenon without a related disease are said to have primary RP. The underlying reason for blood vessel sensitivity to cold is uncertain. Primary RP may be a family trait, suggesting that one or more genes that regulate skin blood flow may be responsible.",
"    </p>",
"    <p>",
"     Primary RP accounts for the majority of cases and is more common among women, younger age groups, and family members of patients with RP. Fortunately, most patients with primary RP are not significantly disabled by the condition and respond well to treatment. It often improves with time, and patients learn to avoid cold and emotional triggers.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Secondary disease",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some patients with secondary RP have an illness, such as scleroderma or systemic lupus erythematosus, that injures or alters the blood vessels and that affects how they react to stimuli such as cold and stress. Secondary RP can be more difficult to manage because it is linked to an underlying condition that can physically damage the blood vessel. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=see_link\">",
"      \"Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      RAYNAUD PHENOMENON CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The normal control of blood vessel responses to cold and other stimuli is complex, involving the central nervous system, peripheral sensory nerves, and molecules released by circulating cells or from the inner lining of the blood vessel itself (called the endothelium).",
"    </p>",
"    <p>",
"     Alpha adrenergic receptors are proteins on the surface of the muscle cells of blood vessels. They help to maintain vascular &ldquo;tone.&rdquo; When stimulated, the receptors trigger blood vessels to constrict in response to certain stimuli such as stress or cold. Receptors that are overly sensitive to adrenalin-like chemicals, released from nerves in the skin, could be responsible for the exaggerated responses to cold that people with RP experience.",
"    </p>",
"    <p>",
"     A RP attack can be triggered by exposure to cold temperature or even by a shift in temperature from warm to cool. As a result, even mildly cold exposures, such as those caused by air-conditioning or by the cold of the refrigerated food section in a grocery store, can cause a RP attack. Experiencing a general body chill can also trigger an attack, even if the hands and feet are kept warm. Feeling emotional stress and being startled can cause an attack of RP due to the release of nerve transmitter substances; these substances activate the alpha receptors on the muscle of the blood vessel, which signal the blood vessels to narrow.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      RAYNAUD PHENOMENON SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most often, a RP attack affects the blood vessels in the fingers. In a typical RP attack, the fingers (or toes) become suddenly cold as the blood vessels constrict. The skin color changes markedly and may become pale (called a &ldquo;white attack&rdquo;) or a purple or blue color (called a &ldquo;blue attack&rdquo;). Usually, an attack of RP begins in a single finger and then spreads to other fingers in both hands. The index, middle, and ring fingers are most commonly involved, while the thumb is often not affected (",
"     <a class=\"graphic graphic_figure graphicRef71633 \" href=\"UTD.htm?0/36/583\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Patients may experience discomfort, including a &ldquo;pins and needles&rdquo; feeling, aching, numbness, or clumsiness of the affected hand(s). The feeling of true pain occurs in secondary RP and is caused by a critical and prolonged loss of blood flow to the tissues.",
"    </p>",
"    <p>",
"     Blood vessels supplying the skin of the ears, nose, face, knees, and nipples can also be affected, and the skin in these areas may become pale or bluish in color after cold exposure. Mottling (a bluish discoloration) of the skin of the arms and legs might also appear. Attacks affecting the toes are also common, although patients tend to complain of these less frequently.",
"    </p>",
"    <p>",
"     Symptoms of RP resolve as the provoking factor (cold or stress) is removed. After leaving the cold area and rewarming, the discoloration resolves after 15 to 20 minutes, and, as normal blood flow resumes, the skin &ldquo;blushes&rdquo; or becomes pink.",
"    </p>",
"    <p>",
"     Patients with severe secondary RP can sometimes experience a serious decrease in blood flow that does not resolve even after the provoking factor or cold is removed. Pain and ulceration of the skin (usually on the tips of the fingers and toes) can result. Serious deeper tissue injury can occur that can lead to finger loss in some patients with a secondary vascular disease causing RP.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      RAYNAUD PHENOMENON DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Raynaud phenomenon is diagnosed based on the patient's description of a typical attack following cold exposure. By asking questions, a healthcare provider can usually tell whether Raynaud phenomenon or another more common condition is causing cold hands or feet.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      RAYNAUD PHENOMENON TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     By taking some simple steps, you can reduce the frequency of RP attacks. Medicine might also be used to help control the symptoms.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Avoid sudden cold exposure &mdash; Use strategies to keep the whole body warm and avoid rapidly shifting temperature, cold breezes, and damp cold conditions. These include dressing warmly, wearing layer clothing such as thermal underwear, donning a hat, and using mittens or gloves.",
"      </li>",
"      <li>",
"       Help end an attack &mdash; Methods include placing the hands under warm water or in a warm place (such as in the armpits) or rotating the arms in a whirling windmill pattern.",
"      </li>",
"      <li>",
"       Avoid smoking &mdash; Nicotine and other chemicals in cigarettes cause the blood vessels to constrict and can aggravate RP. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"        \"Patient information: Quitting smoking (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Avoid medications that cause vasoconstriction &mdash; Such medications include decongestants containing phenylephrine or pseudoephedrine, other amphetamines, diet pills, some migraine remedies containing ergotamine, herbs containing ephedra, and medications used to treat attention deficit disorder (ADD) such as methylphenidate, dextroamphetamine-amphetamine, and atomoxetine.",
"      </li>",
"      <li>",
"       Reduce stress &mdash; Reduce stress and use relaxation techniques to reduce anxiety.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Medicine",
"     </span>",
"     &nbsp;&mdash;&nbsp;If the measures above are not sufficient, your doctor or nurse might recommend a medicine. Medicines called calcium channel blockers are the most commonly used and can reduce both the frequency and the severity of RP attacks. You might need to take the medicine when you are exposed to cold temperatures, such as during the winter months.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Secondary Raynaud phenomenon",
"     </span>",
"     &nbsp;&mdash;&nbsp;More aggressive treatment is sometimes needed for people with secondary Raynaud phenomenon. Most people need a medicine to reduce the frequency of attacks and to prevent injury to the skin on the fingers and toes.",
"    </p>",
"    <p>",
"     Several medicines have been studied for people who do not respond to calcium channel blockers. These include nitrates (topical nitroglycerin), blood pressure medications (prazosin or angiotensin receptor inhibitors like losartan), phosphodiesterase inhibitors (sildenafil, pentoxifylline, or cilostazol), antidepressant medication (fluoxetine), or prostaglandins (prostacyclin).",
"    </p>",
"    <p>",
"     Hospitalization may be required if an attack of RP does not resolve and if blood flow to a finger or toe is seriously restricted. Treatment in this situation requires additional medications to dilate the blood vessels and to prevent blood clots. In some cases, medication or surgery may be used to block the nerves that trigger vasoconstriction in the affected area. Botox injections near the base of the fingers may be helpful.",
"    </p>",
"    <p>",
"     In rare instances, treatment may be ineffective in reversing the vasoconstriction. Ulceration of the skin may result. If all other treatments have failed and if deep tissue injury has occurred due to lack of blood flow, surgical amputation of the affected finger or toe may become necessary.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287295939\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H585997\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/4/35905?source=see_link\">",
"      Patient information: Raynaud disease (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H586014\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=see_link\">",
"      Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=see_link\">",
"      Clinical manifestations and diagnosis of the Raynaud phenomenon",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28200?source=see_link\">",
"      Initial treatment of the Raynaud phenomenon",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23719?source=see_link\">",
"      Pathogenesis of the Raynaud phenomenon",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28138?source=see_link\">",
"      Treatment of the Raynaud phenomenon resistant to initial therapy",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The National Institutes of Health (NIH)",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The National Institute of Arthritis and Musculoskeletal and Skin Diseases",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niams.nih.gov/hi\">",
"        www.niams.nih.gov/hi",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Foundation",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/conditions-treatments/disease-center/raynauds-phenomenon/\">",
"        file://www.arthritis.org/conditions-treatments/disease-center/raynauds-phenomenon/",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Society",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.ca/\">",
"        www.arthritis.ca",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American college of rheumatology",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.rheumatology.org/\">",
"        www.rheumatology.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?29/49/30481/abstract/1-9\">",
"      1-9",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?29/49/30481?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/1\">",
"      Wigley FM, Flavahan NA. Raynaud's phenomenon. Rheum Dis Clin North Am 1996; 22:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/2\">",
"      Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001; 357:2042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/3\">",
"      Wigley FM. Clinical practice. Raynaud's Phenomenon. N Engl J Med 2002; 347:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/4\">",
"      Flavahan NA, Flavahan S, Mitra S, Chotani MA. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheum Dis Clin North Am 2003; 29:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/5\">",
"      Boin F, Wigley FM. Understanding, assessing and treating Raynaud's phenomenon. Curr Opin Rheumatol 2005; 17:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/6\">",
"      Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 2005; 44:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/7\">",
"      Henness S, Wigley FM. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review. Curr Opin Rheumatol 2007; 19:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/8\">",
"      Herrick AL. Contemporary management of Raynaud's phenomenon and digital ischaemic complications. Curr Opin Rheumatol 2011; 23:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30481/abstract/9\">",
"      Pope JE. Raynaud's phenomenon (primary). Clin Evid (Online) 2011; 2011.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f29_49_30481=[""].join("\n");
var outline_f29_49_30481=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           RAYNAUD PHENOMENON RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           RAYNAUD PHENOMENON CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           RAYNAUD PHENOMENON SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           RAYNAUD PHENOMENON DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           RAYNAUD PHENOMENON TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/36/583\" title=\"figure 1\">",
"           Acute Raynaud phenomenon PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30482="Immunohistochem CUP";
var content_f29_49_30482=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 591px\">",
"   <div class=\"ttl\">",
"    Immunohistochemistry in undifferentiated neoplasms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 571px; height: 717px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dabbs DJ. Immunohistology of metastatic carcinoma of unknown primary. In: Diagnostic Immunohistochemistry, 2nd edition, Dabbs DJ (Ed), Elsevier, Philadelphia 2006. p. 180. Copyright &copy;2006 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30482=[""].join("\n");
var outline_f29_49_30482=null;
var title_f29_49_30483="Arteriovenous malformation III";
var content_f29_49_30483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary arteriovenous malformation in the right upper lobe",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal CT image with mediastinal window settings show a right upper lobe solitary pulmonary nodule with several tentacle-like extensions suspicious for an arteriovenous malformation. The enhancement of the nodule is identical to that of the central pulmonary arterial branches.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30483=[""].join("\n");
var outline_f29_49_30483=null;
var title_f29_49_30484="Anemia caused by low iron";
var content_f29_49_30484=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Anemia caused by low iron (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30484/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30484/contributors\" id=\"au5720\">",
"       Stanley L Schrier, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30484/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30484/contributors\" id=\"se4110\">",
"       William C Mentzer, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?29/49/30484/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30484/contributors\" id=\"de4624\">",
"       Stephen A Landaw, MD, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?29/49/30484?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      IRON DEFICIENCY ANEMIA OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Anemia is a disorder that can be caused by a number of different conditions, including heavy menstrual periods, cancer, bleeding in the digestive tract, and sickle cell disease, just to name a few. Iron deficiency anemia is a specific type of anemia that in the Western world is almost always caused by blood loss. Very rarely, decreased absorption of iron from foods plays a role.",
"    </p>",
"    <p>",
"     Iron deficiency anemia can be mild or severe, and can be temporary or chronic. The condition is common in the United States, affecting 1 to 2 percent of adults. It is even more common in developing countries, primarily due to deficiencies of iron in their diet.",
"    </p>",
"    <p>",
"     This topic will review the signs and symptoms, potential causes, diagnostic tests, and treatment of iron deficiency anemia in adults.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS ANEMIA?",
"     </span>",
"    </p>",
"    <p>",
"     Anemia is defined as a decreased number of red blood cells, as measured by one of the following blood tests:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hemoglobin (Hgb) is a pigment that carries oxygen in the red blood cells. Iron is a critical component of hemoglobin; without iron, hemoglobin cannot be formed and thus cannot carry or release oxygen.",
"      </li>",
"      <li>",
"       Hematocrit is the percent of a sample of whole blood occupied by intact red blood cells (RBCs).",
"      </li>",
"      <li>",
"       RBC count is the number of red blood cells in a certain amount of whole blood (usually one microliter).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Iron deficiency anemia occurs when there is an insufficient amount of iron in the body to make hemoglobin. When the quantity of hemoglobin is reduced, red blood cells carry less oxygen throughout the body. However, a person may not have signs or symptoms of anemia until their hemoglobin level is reduced by 20 percent or more.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      ANEMIA SIGNS AND SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Many people with iron deficiency anemia have no symptoms at all. Of those who do, the most common symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Weakness",
"      </li>",
"      <li>",
"       Headache",
"      </li>",
"      <li>",
"       Irritability",
"      </li>",
"      <li>",
"       Fatigue",
"      </li>",
"      <li>",
"       Difficulty exercising (due to shortness of breath, rapid heartbeat)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Less common symptoms of iron deficiency include brittle nails, sore tongue, restless legs syndrome, pica, and pagophagia. Pica is an abnormal craving to eat non-food items, such as clay or dirt, paper products, or starch (eg, cornstarch). Pagophagia is an abnormal craving to eat ice.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      ANEMIA CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Two common causes of iron deficiency anemia are blood loss (most common) and very rarely decreased absorption of iron from food.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Blood loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;The source of blood loss may be obvious, such as repeated blood donations, trauma, surgery, or in women who have heavy menstrual bleeding or multiple pregnancies over a short period of time. In other cases, the source of the blood loss is not visible, as in someone who has bleeding in their digestive tract.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Decreased iron absorption",
"     </span>",
"     &nbsp;&mdash;&nbsp;Normally, the body absorbs iron from food through the gastrointestinal tract. If the GI tract is not functioning correctly, as in people with certain conditions (eg, celiac disease, gastritis), an inadequate amount of iron may be absorbed, leading to iron deficiency anemia. This is a much less common cause of iron deficiency anemia than blood loss.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Other causes",
"     </span>",
"     &nbsp;&mdash;&nbsp;A common cause of iron deficiency anemia in developing countries is a lack of foods that contain iron. However, this is a rare problem in adults in developed countries such as the United States because many foods have added iron (eg, breakfast cereal, bread, pasta).",
"    </p>",
"    <p>",
"     Vegetarians are at increased risk for developing iron deficiency anemia because iron from plant sources is not absorbed as readily as iron from meat sources. Vegetarian sources of iron are discussed below. (See",
"     <a class=\"local\" href=\"#H22\">",
"      'Iron and diet'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     Pregnant women often develop iron deficiency anemia because of the increased iron requirements of the growing fetus and placenta, and the increased volume of blood circulating in the woman's body during pregnancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      ANEMIA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     A person may be diagnosed with iron deficiency anemia after blood testing done to evaluate symptoms or after testing done for another, unrelated reason. The initial workup generally involves a medical history, physical examination, and blood tests.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Complete blood count",
"     </span>",
"     &nbsp;&mdash;&nbsp;A complete blood count (CBC) is a group of tests that includes a red blood cell (RBC) count, hemoglobin, and hematocrit. It also includes the mean corpuscular volume (MCV, referring to RBC size), mean corpuscular hemoglobin (MCH, referring to the amount of hemoglobin per RBC), and others.",
"    </p>",
"    <p>",
"     In people with iron deficiency anemia, the RBC count, Hgb, and Hct are lower than normal. The MCV and MCH are also usually lower than normal, indicating that the RBCs are smaller (called microcytic) and carry less Hgb than normal RBCs.",
"    </p>",
"    <p>",
"     As part of the complete blood count, a small amount of blood is examined under a microscope. The shape, color, and size of the RBCs can help to determine the type of anemia.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Other blood tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;In many cases, iron deficiency anemia is suspected based upon the results of the medical history, the CBC, and the blood smear. In other cases, further testing may be done to confirm the diagnosis.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Serum iron &mdash; Measures how much iron is circulating in the blood",
"      </li>",
"      <li>",
"       Total iron binding capacity (TIBC or transferrin) &mdash; Measures the amount of a protein (transferrin) in the blood that is capable of transporting iron to RBCs or body stores",
"      </li>",
"      <li>",
"       Transferrin saturation &mdash; Measures the percentage of iron-binding sites on transferrin that are occupied by iron",
"      </li>",
"      <li>",
"       Ferritin &mdash; Measures ferritin, a protein that stores iron in the liver and spleen. Ferritin is a more accurate measure of the body's iron reserves than the other blood tests listed above.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In a person with iron deficiency anemia, the serum iron, transferrin saturation, and ferritin are often lower than normal and the TIBC may be higher than normal.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Search for source of blood and iron loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;Once the diagnosis of iron deficiency anemia is made, the next step is to try to identify the cause of blood or iron loss. The healthcare provider may ask questions about the following situations, which can increase the risk of developing iron deficiency anemia:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       For women, history of menstrual bleeding, pregnancy, delivery, breastfeeding",
"      </li>",
"      <li>",
"       Multiple blood donations",
"      </li>",
"      <li>",
"       GI problems such as ulcer, H. pylori infection, celiac disease",
"      </li>",
"      <li>",
"       Family or personal history of bleeding disorders",
"      </li>",
"      <li>",
"       Family or personal history of colon cancer",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Depending upon the answers to these questions, further testing may be recommended. As an example, if bleeding is suspected in the digestive tract, a stool test (eg, Hemoccult) may be performed. If the stool test is positive for blood, the gastrointestinal tract should be examined to determine the source of the bleeding. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7541?source=see_link\">",
"      \"Patient information: Colon and rectal cancer screening (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      ANEMIA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment for iron deficiency anemia is an iron supplement, which may be taken by mouth or given as an injection (called parenteral iron). This iron is needed to increase production of hemoglobin and also to rebuild the body's iron reserves.",
"    </p>",
"    <p>",
"     Oral iron tablets are recommended in most people with iron deficiency anemia. Injections of iron are usually reserved for people whose digestive tract is unable to adequately absorb iron or in those who are unable to tolerate oral iron.",
"    </p>",
"    <p>",
"     A blood transfusion may be given if a person is actively bleeding",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     the person's hemoglobin or hematocrit levels are very low.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Oral iron",
"     </span>",
"     &nbsp;&mdash;&nbsp;Oral iron tablets are usually a safe, inexpensive, and effective treatment for people with iron deficiency. The following tips are recommended:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Enteric coated (EC) iron tablets are not recommended because iron is best absorbed from the duodenum and jejunum (the first and middle parts of the small intestine). EC iron releases iron further down in the intestinal tract, where it is not as easily absorbed. In some cases, the EC iron tablet passes through the entire intestinal tract with the coating intact, meaning that none of the iron was absorbed.",
"      </li>",
"      <li>",
"       Certain foods and medicines can reduce the effectiveness of iron tablets. Iron tablets should not be taken with food, certain antibiotics, tea, coffee, calcium supplements, or milk. Iron should be taken 1 hour before or 2 hours after these items. Iron should be taken 2 hours before or 4 hours after antacids.",
"      </li>",
"      <li>",
"       Iron tablets are best absorbed in an acidic environment; taking iron with one 250 mg vitamin C tablet or orange juice can enhance iron absorption.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Types of oral iron",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are several types of oral iron. The primary difference between the types is the amount of elemental iron each contains. There is no evidence that one form of iron is more effective than another.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Ferrous fumarate &mdash; 106 mg elemental",
"       <span class=\"nowrap\">",
"        iron/tablet",
"       </span>",
"      </li>",
"      <li>",
"       Ferrous sulfate &mdash; 65 mg elemental",
"       <span class=\"nowrap\">",
"        iron/tablet",
"       </span>",
"      </li>",
"      <li>",
"       Ferrous sulfate liquid &mdash; 44 mg elemental",
"       <span class=\"nowrap\">",
"        iron/teaspoon",
"       </span>",
"       (5 mL)",
"      </li>",
"      <li>",
"       Ferrous gluconate &mdash; 28 to 36 mg",
"       <span class=\"nowrap\">",
"        iron/tablet",
"       </span>",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The recommended daily dose of elemental iron for adults with iron deficiency in adults is 150 to 200",
"     <span class=\"nowrap\">",
"      mg/day.",
"     </span>",
"     The least expensive form of iron is iron sulfate. As an example, one 325 mg iron sulfate tablet taken three times per day supplies 195 mg of elemental iron per day. A healthcare provider can help to determine what dose and type of iron is most appropriate.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people experience nausea, constipation, stomach upset,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     vomiting after taking oral iron. Options for dealing with these side effects include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Take a smaller dose",
"      </li>",
"      <li>",
"       Use a formulation with a lower elemental iron content (eg, ferrous gluconate instead of ferrous sulfate)",
"      </li>",
"      <li>",
"       Take the liquid form of ferrous sulfate and adjust the dose until symptoms are tolerable.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Taking iron tablets will turn the stool a dark, almost black color. This is to be expected, and does NOT mean that the iron tablets are causing intestinal bleeding.",
"    </p>",
"    <p>",
"     Children under six years are at particular risk of iron poisoning, making it very important to store iron tablets out of the reach of children.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Duration of treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment with oral iron is recommended for as long as it takes the hemoglobin and hematocrit to return to normal. A blood count is often repeated one to two months after starting iron to determine if the treatment has been effective.",
"    </p>",
"    <p>",
"     When the Hgb has returned to normal, treatment with iron may be discontinued. However, some clinicians recommend continuing the iron for at least six months after the Hgb normalizes in order to replenish the body's iron stores.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      If oral iron does not increase hemoglobin",
"     </span>",
"     &nbsp;&mdash;&nbsp;On occasion, a person's hemoglobin will not improve despite treatment with oral iron. There are several possible reasons for this. The next step in this situation depends upon why the person did not respond.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Parenteral iron",
"     </span>",
"     &nbsp;&mdash;&nbsp;Iron may be given by injection in certain situations, such as in people who cannot tolerate oral iron tablets or whose gastrointestinal tract cannot absorb an adequate amount of iron from pills (eg, due to inflammatory bowel disease or in patients undergoing dialysis or treatment for cancer). Parenteral iron is usually given in a healthcare provider's office or hospital. The medication is infused into a vein slowly, over the course of an hour or more.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Side effects, such as itching, heart palpitations, and dizziness, can occur with parenteral iron. One form of parenteral iron, iron dextran, can cause serious or even life-threatening allergic reactions in some people. Other forms of parenteral iron, including iron sucrose and ferric gluconate complex, have much lower risks of life-threatening side effects. As a result, most clinicians recommend non-dextran forms of parenteral iron.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Blood transfusion",
"     </span>",
"     &nbsp;&mdash;&nbsp;Blood transfusion is a term that may be used to describe the use of packed red blood cells (PRBCs) in a person with anemia. PRBCs are prepared from whole blood by eliminating most of the plasma (the liquid part of blood) and virtually all of the white blood cells and platelets.",
"    </p>",
"    <p>",
"     In people with iron deficiency anemia, a blood transfusion usually involves giving one or more units of packed red blood cells into a vein. Each unit of PRBCs contains approximately 200 mg of iron and will raise the hemoglobin by about 1",
"     <span class=\"nowrap\">",
"      gm/dL.",
"     </span>",
"    </p>",
"    <p>",
"     Blood transfusions are generally reserved for people who have a low or unstable blood pressure due to bleeding,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     if the person's organs (brain, heart) are being deprived of oxygen as a result of severe anemia. A transfusion may also be recommended in select cases if the person is not actively bleeding and has a stable blood pressure but their hemoglobin or hematocrit level is very low (eg, hemoglobin less than 7",
"     <span class=\"nowrap\">",
"      g/dL",
"     </span>",
"     or hematocrit less than 20 percent).",
"    </p>",
"    <p>",
"     Blood transfusion is described in detail in a separate topic. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"      \"Patient information: Blood donation and transfusion (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;There can be side effects of blood transfusion, with the most common being fever, chills, and mild shortness of breath. However, this only occurs in 0.15 to 0.19 percent of transfusions. More serious or even life-threatening allergic reactions can occur, although this is not common.",
"    </p>",
"    <p>",
"     The risk of infection with the hepatitis C virus or the virus causing AIDS is extremely low because of better screening of blood donors as well as improved laboratory testing. These infections occur only once for every two million transfusions.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Iron and diet",
"     </span>",
"     &nbsp;&mdash;&nbsp;Although dietary iron is important in preventing iron deficiency, people with iron deficiency anemia need more iron than they can consume through their diet alone. In a 2000 calorie diet, there is only about 10 mg of elemental iron (compared to 65 mg in one 325 mg iron sulfate tablet). Therefore, increasing dietary iron alone is not usually recommended as a treatment for iron deficiency anemia, although it may be recommended in combination with iron therapy.",
"    </p>",
"    <p>",
"     Dietary sources of iron are found in meat, grains, fruits, and vegetables (",
"     <a class=\"graphic graphic_table graphicRef73962 \" href=\"UTD.htm?24/36/25166\">",
"      table 1",
"     </a>",
"     ). For people who do not eat meat, good plant sources of iron include whole or enriched breads or grains, iron-fortified cereals, legumes, green leafy vegetables, dried fruits, soy products, blackstrap molasses, bulgur, and wheat germ. To maximize absorption, iron-rich foods should not be consumed with coffee or tea. Taking vitamin C or drinking orange juice with high iron foods can further enhance absorption.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      ANEMIA PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     People who have had iron deficiency anemia once may be at increased risk for developing it again, depending upon why they developed anemia originally. In these people, a daily multivitamin or iron supplement may be recommended to maintain the body's iron stores.",
"    </p>",
"    <p>",
"     However, iron supplements and multivitamins that contain iron should not be taken without consulting a healthcare provider due to the potential risk of iron overdose. Most men and postmenopausal women do",
"     <strong>",
"      not",
"     </strong>",
"     need supplemental iron unless they have an underlying illness that reduces iron absorption or causes bleeding.",
"    </p>",
"    <p>",
"     Increasing dietary iron can also help to maintain iron stores. (See",
"     <a class=\"local\" href=\"#H22\">",
"      'Iron and diet'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287485023\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12677807\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/53/19281?source=see_link\">",
"      Patient information: Anemia caused by low iron (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41906?source=see_link\">",
"      Patient information: Nutrition before and during pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/52/22338?source=see_link\">",
"      Patient information: Blood donation (giving blood) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/29/20946?source=see_link\">",
"      Patient information: Restless legs syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/25/6546?source=see_link\">",
"      Patient information: Orthostatic hypotension (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/54/41826?source=see_link\">",
"      Patient information: Angiodysplasia of the GI tract (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/26/5537?source=see_link\">",
"      Patient information: Complete blood count (CBC) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=see_link\">",
"      Patient information: Medicines for chronic kidney disease (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12677872\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7541?source=see_link\">",
"      Patient information: Colon and rectal cancer screening (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"      Patient information: Blood donation and transfusion (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=see_link\">",
"      Anemias due to decreased red cell production",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=see_link\">",
"      The approach to the patient who refuses blood transfusion",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23914?source=see_link\">",
"      Hematologic consequences of malignancy: Anemia and bleeding",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=see_link\">",
"      Hematologic manifestations of HIV infection: Anemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=see_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4329?source=see_link\">",
"      Iron requirements and iron deficiency in adolescents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=see_link\">",
"      Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42214?source=see_link\">",
"      Transfusion reactions caused by chemical and physical agents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6710?source=see_link\">",
"      Transfusion-associated graft-versus-host disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37766?source=see_link\">",
"      Transfusion-associated immune and non immune-mediated hemolysis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=see_link\">",
"      Transfusion-related acute lung injury (TRALI)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/14/10471?source=see_link\">",
"      Transfusion transmitted bacterial infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=see_link\">",
"      Treatment of anemia due to iron deficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/37/21081?source=see_link\">",
"      Use of red blood cells for transfusion",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/000584.htm\">",
"      www.nlm.nih.gov/medlineplus/ency/article/000584.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/health/dci/Diseases/ida/ida_diagnosis.html\">",
"      www.nhlbi.nih.gov/health/dci/Diseases/ida/ida_diagnosis.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Center for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/nccdphp/dnpa/nutrition/nutrition_for_everyone/basics/iron.htm\">",
"      www.cdc.gov/nccdphp/dnpa/nutrition/nutrition_for_everyone/basics/iron.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?29/49/30484/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?29/49/30484?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30484/abstract/1\">",
"      Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47(RR-3):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30484/abstract/2\">",
"      Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008; 48:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30484/abstract/3\">",
"      Baker WF Jr. Iron deficiency in pregnancy, obstetrics, and gynecology. Hematol Oncol Clin North Am 2000; 14:1061.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f29_49_30484=[""].join("\n");
var outline_f29_49_30484=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           IRON DEFICIENCY ANEMIA OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS ANEMIA?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           ANEMIA SIGNS AND SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           ANEMIA CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           ANEMIA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           ANEMIA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           ANEMIA PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H24\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?24/36/25166\" title=\"table 1\">",
"           Dietary sources of iron PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30485="Dronabinol: Drug information";
var content_f29_49_30485=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dronabinol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/27/13748?source=see_link\">",
"    see \"Dronabinol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/40/30340?source=see_link\">",
"    see \"Dronabinol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16116938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Marinol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F163505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Marinol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F163524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiemetic;",
"     </li>",
"     <li>",
"      Appetite Stimulant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F163507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antiemetic:",
"     </b>",
"     Oral: 5 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     1-3 hours before chemotherapy, then give 5 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose every 2-4 hours after chemotherapy for a total of 4-6 doses/day; dose may be increased up to a maximum of 15 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose if needed (dosage may be increased by 2.5 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     increments).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Appetite stimulant (AIDS-related):",
"     </b>",
"     Oral: Initial: 2.5 mg twice daily (before lunch and dinner); titrate up to a maximum of 20 mg/day.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F163518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/40/30340?source=see_link\">",
"      see \"Dronabinol: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antiemetic: Oral: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F163508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15804935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F163509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Usual dose should be reduced in patients with severe liver failure.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F163483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, soft gelatin, oral: 2.5 mg [contains sesame oil], 5 mg [contains sesame oil], 10 mg [contains sesame oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Marinol&reg;: 2.5 mg, 5 mg, 10 mg [contains sesame oil]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F163466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F163526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F163485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Chemotherapy-associated nausea and vomiting refractory to other antiemetic(s); AIDS-related anorexia",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F621841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cancer-related anorexia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F163532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Dronabinol may be confused with droperidol",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F163522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not always specified.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;1%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Palpitations, tachycardia, vasodilation/facial flushing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Euphoria (8% to 24%, dose related), abnormal thinking (3% to 10%), dizziness (3% to 10%), paranoia (3% to 10%), somnolence (3% to 10%), amnesia, anxiety, ataxia, confusion, depersonalization, hallucination",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (3% to 10%), nausea (3% to 10%), vomiting (3% to 10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Conjunctivitis, depression, diarrhea, fatigue, fecal incontinence, flushing, hypotension, myalgia, nightmares, seizure, speech difficulties, tinnitus, vision difficulties",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F163488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dronabinol, cannabinoids, sesame oil, or any component of the formulation, or marijuana; should be avoided in patients with a history of schizophrenia",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F163470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists (drug is psychoactive substance in marijuana). Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; reduce dosage with severe impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychiatric disorders: Use with caution in patients with mania, depression, or schizophrenia; careful psychiatric monitoring is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder; may lower seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depressants: Effects may be potentiated when used with other psychoactive drugs, sedatives and/or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may cause postural hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: May cause withdrawal symptoms upon abrupt discontinuation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F163475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergic Agents: May enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cocaine: May enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ritonavir: May increase the serum concentration of Dronabinol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: Cannabinoids may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F163500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Administration with high-lipid meals may increase absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease dronabinol levels.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F163478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13386485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F163512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F621844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Capsules contain sesame oil.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F163490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Dronabinol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (60): $353.57",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (60): $735.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (60): $1351.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Marinol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (60): $620.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (60): $1291.38",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (60): $2371.45",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F163480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CNS effects, heart rate, blood pressure, behavioral profile",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F163484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antinauseant effects: 5-10 ng/mL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Elevat (ZA);",
"     </li>",
"     <li>",
"      Marinol (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F163469\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Unknown, may inhibit endorphins in the brain's emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action. Some pharmacologic effects appear to involve sympathimometic activity; tachyphylaxis to some effect (eg, tachycardia) may occur, but appetite-stimulating effects do not appear to wane over time. Antiemetic activity may be due to effect on cannabinoid receptors (CB1) within the central nervous system.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F163487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Peak effect: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Duration: 24 hours (appetite stimulation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: 90% to 95%; 10% to 20% of dose gets into systemic circulation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 10 L/kg; dronabinol is highly lipophilic and distributes to adipose tissue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 97% to 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic to at least 50 metabolites, some of which are active; 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC) is the major metabolite; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Dronabinol: 25-36 hours (terminal); Dronabinol metabolites: 44-59 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 0.5-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (50% as unconjugated metabolites, 5% as unchanged drug); urine (10% to 15% as acid metabolites and conjugates)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Anderson PO and Muire GG, &ldquo;Delta-9-Tetrahydrocannabinol as an Antiemetic,&rdquo;",
"      <i>",
"       Am J Hosp Pharm",
"      </i>",
"      , 1981, 38:639-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/6269423/pubmed\" id=\"6269423\" target=\"_blank\">",
"        6269423",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cat LK and Coleman RL, &ldquo;Treatment for HIV Wasting Syndrome,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(5):595-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/8068997/pubmed\" id=\"8068997\" target=\"_blank\">",
"        8068997",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Plasse TF, Gorter RW, Krasnow SH, et al, \"Recent Clinical Experience with Dronabinol,\"",
"      <i>",
"       Pharmacol Biochem Behav",
"      </i>",
"      , 1991, 40(3):695-700.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/1666930/pubmed\" id=\"1666930\" target=\"_blank\">",
"        1666930",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Struwe M, Kaempfer SH, Geiger CJ, et al, &ldquo;Effect of Dronabinol on Nutritional Status in HIV Infection,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1993, 27(7-8):827-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/8395916/pubmed\" id=\"8395916\" target=\"_blank\">",
"        8395916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tramer MR, Carroll D, Campbell FA, et al, &ldquo;Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic Review,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 2001, 323(7303):16-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/11440936/pubmed\" id=\"11440936\" target=\"_blank\">",
"        11440936",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Voth EA and Schwartz RH, &ldquo;Medicinal Applications of Delta-9-Tetrahydrocannabinol and Marijuana,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1979, 126(10):791-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/49/30485/abstract-text/9148653/pubmed\" id=\"9148653\" target=\"_blank\">",
"        9148653",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9394 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-7B7E1375F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30485=[""].join("\n");
var outline_f29_49_30485=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16116938\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163505\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163524\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163507\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163518\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163508\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804935\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163509\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163483\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163466\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163526\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163485\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F621841\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163532\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163522\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163488\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163470\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299237\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163475\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163500\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163478\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13386485\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163512\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F621844\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163490\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163480\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163484\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038605\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163469\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163487\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9394\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9394|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/27/13748?source=related_link\">",
"      Dronabinol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/40/30340?source=related_link\">",
"      Dronabinol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30486="Fibrosing cholestatic hepatitis";
var content_f29_49_30486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    Fibrosing cholestatic hepatitis after liver transplantation for hepatitis B virus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fibrosing cholestatic hepatitis in a patient six months after liver transplantation for cirrhosis due to hepatitis B virus.",
"    <br/>",
"    (A) Balloon degeneration of hepatocytes, periportal fibrosis, and marked cholestasis but minimal inflammation.",
"    <br/>",
"    (B) Immunohistochemical staining reveals intense and widespread accumulation of HBsAg and HBcAg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy Robert J Fontana, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30486=[""].join("\n");
var outline_f29_49_30486=null;
var title_f29_49_30487="Radiographic appearance of developmental anomalies of the lung";
var content_f29_49_30487=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiographic appearance of developmental anomalies of the lung",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30487/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/49/30487/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental anomalies of the lung can be categorized as bronchopulmonary anomalies, vascular anomalies, or combined anomalies (ie, hybrid pulmonary malformations) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. They are primarily due to aberrant intrauterine development; abnormalities during postnatal lung development are uncommon. Recognition of developmental anomalies is important because they are frequently mimicked by more ominous acquired abnormalities and they can cause complications during infancy, early childhood, or adulthood.",
"   </p>",
"   <p>",
"    The radiographic appearances of the major developmental anomalies of the lung are discussed in this topic review. Other aspects of the developmental anomalies (eg, clinical presentation, diagnosis, treatment) are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/11/44214?source=see_link\">",
"     \"Congenital lobar emphysema\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/50/810?source=see_link\">",
"     \"Congenital pulmonary airway (cystic adenomatoid) malformation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link\">",
"     \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Diagnostic evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BRONCHOPULMONARY ANOMALIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchopulmonary anomalies are caused by insults to the lung bud, the embryonic structure from which airways and parenchyma develop. Examples of bronchopulmonary anomalies include agenesis, congenital bronchial atresia, congenital lobar emphysema, congenital cystic adenomatoid malformation (now renamed as congenital pulmonary airway malformation [CPAM]), bronchogenic cyst, tracheal bronchus, tracheal diverticulum, and accessory cardiac bronchus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Agenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agenesis exists when a lung or lobe, its bronchi, and its vessels fail to develop. Radiographically, agenesis of a lung appears nearly identical to a pneumonectomy and agenesis of a lobe mimics lobar collapse or a lobectomy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64749 \" href=\"UTD.htm?19/55/20338\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58155 \" href=\"UTD.htm?11/62/12258\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/1\">",
"     1",
"    </a>",
"    ]. Associated anomalies of ribs or the spine are common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Congenital bronchial atresia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital bronchial atresia exists when a proximal bronchus is absent, but the distal bronchial tree is preserved. The apicoposterior segment of the left upper lobe bronchus is involved most frequently, followed by segmental bronchi of the right upper lobe, right middle lobe, and right lower lobe [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/4\">",
"     4",
"    </a>",
"    ]. Its radiographic appearance is due to mucoid impaction distal to the occluded bronchus and hyperinflation of the affected segment. Specifically, a perihilar mass is surrounded by a halo of lung that is hyperexpanded due to collateral ventilation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82218 graphicRef63130 \" href=\"UTD.htm?5/59/6071\">",
"     image 3A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82511 \" href=\"UTD.htm?11/55/12159\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58630 graphicRef60010 graphicRef67715 \" href=\"UTD.htm?21/23/21879\">",
"     image 5A-C",
"    </a>",
"    ). Congenital bronchial atresia is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H25#H25\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Bronchial atresia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Congenital lobar emphysema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital lobar emphysema is more appropriately referred to as congenital lobar hyperinflation. It is characterized by a hyperexpanded and hyperlucent lobe, adjacent atelectasis, and contralateral mediastinal shift (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70967 \" href=\"UTD.htm?25/44/26305\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62270 \" href=\"UTD.htm?27/27/28080\">",
"     image 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82610 \" href=\"UTD.htm?6/31/6655\">",
"     image 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/5\">",
"     5",
"    </a>",
"    ]. Congenital lobar emphysema is most frequently the result of a ball-valve obstruction with gas trapping, not true emphysema. It can also, on rare occasions, be the result of a hyperalveolar lobe with an excessive number of alveoli of normal size. Occasionally, the lobe is opacified in newborns due to retained fetal lung liquid. Congenital lobar emphysema is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/11/44214?source=see_link\">",
"     \"Congenital lobar emphysema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Congenital pulmonary airway malformation (CPAM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital pulmonary airway malformation (CPAM; previously known as congenital cystic adenomatoid malformation, CCAM) is characterized by adenomatoid proliferation of bronchioles resulting in cysts rather than alveoli. Radiographically, a large gas-filled cyst, a conglomerate of gas-filled cysts, or a solid mass (ie, liquid-filled cyst) can be seen (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61385 graphicRef73128 \" href=\"UTD.htm?2/17/2327\">",
"     image 9A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59629 \" href=\"UTD.htm?15/7/15473\">",
"     image 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67292 \" href=\"UTD.htm?14/9/14480\">",
"     image 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52148 graphicRef79904 \" href=\"UTD.htm?4/4/4166\">",
"     image 12A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/6\">",
"     6",
"    </a>",
"    ]. These lesions can cause mass effect with contralateral mediastinal shift. CPAM is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/50/810?source=see_link\">",
"     \"Congenital pulmonary airway (cystic adenomatoid) malformation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bronchogenic cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchogenic cysts can be mediastinal or intrapulmonary. Mediastinal bronchogenic cysts appear as a subcarinal, paratracheal, paraaortic, or aortico-pulmonary window mass (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74804 graphicRef51294 \" href=\"UTD.htm?30/47/31477\">",
"     image 13A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55788 graphicRef63545 graphicRef65152 \" href=\"UTD.htm?33/57/34713\">",
"     image 14A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77346 graphicRef72317 graphicRef72838 \" href=\"UTD.htm?6/1/6168\">",
"     image 15A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56360 graphicRef53262 \" href=\"UTD.htm?38/17/39189\">",
"     image 16A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70209 graphicRef63014 \" href=\"UTD.htm?31/21/32086\">",
"     image 17A-B",
"    </a>",
"    ). On computed tomography (CT), most are low attenuation (like water), but some display higher attenuation (like soft tissue) due to protein or calcium salts [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intrapulmonary bronchogenic cysts appear as sharply outlined masses, which may contain gas due to previous or current infection (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55233 \" href=\"UTD.htm?27/54/28514\">",
"     image 18",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68031 \" href=\"UTD.htm?6/15/6385\">",
"     image 19",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82030 \" href=\"UTD.htm?32/8/32911\">",
"     image 20",
"    </a>",
"    ). A rudimentary bronchus may appear as a tail. On a CT scan, adjacent strands of atelectasis or scarring may be visible. Mosaic attenuation in the lung parenchyma surrounding a bronchogenic cyst has also been described. Bronchogenic cysts are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H29#H29\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Bronchogenic cyst'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tracheal bronchus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tracheal bronchus (ie, &ldquo;pig bronchus&rdquo;) is an abnormal bronchus that originates from the trachea and usually supplies the right upper lobe or one of its segments (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64925 \" href=\"UTD.htm?3/53/3921\">",
"     image 21",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76683 \" href=\"UTD.htm?7/21/7519\">",
"     image 22",
"    </a>",
"    ). Tracheal bronchi are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H21#H21\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheal bronchus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Tracheal diverticulum",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tracheal diverticulum (ie, tracheocele) is a gas-containing outpouching of the proximal trachea (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75221 \" href=\"UTD.htm?16/29/16863\">",
"     image 23",
"    </a>",
"    ). It is usually encountered on the posterolateral right side, at the level of the thoracic inlet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Accessory cardiac bronchus",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accessory cardiac bronchus is an abnormal bronchus that arises from the inferomedial wall of the right main bronchus or bronchus intermedius (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74431 \" href=\"UTD.htm?19/51/20272\">",
"     image 24",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/7\">",
"     7",
"    </a>",
"    ]. It either ends blindly or has a small extra segment of lung parenchyma attached to it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     VASCULAR ANOMALIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary vascular anomalies are caused by aberrant angiogenesis. Examples of pulmonary vascular anomalies include proximal interruption of a central pulmonary artery, an anomalous origin of the left pulmonary artery from the right pulmonary artery, partial or total anomalous pulmonary venous return, pulmonary arteriovenous malformation, and maldevelopment of lymphatic vessels, such as cystic hygroma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Proximal interruption of a central pulmonary artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood flow through the central pulmonary arteries (ie, the main pulmonary artery, right pulmonary artery, and left pulmonary artery) may be interrupted due to pulmonary artery agenesis, pulmonary atresia, or pulmonary artery stenosis. Radiographically, the ipsilateral hilum and lung are small and receive arterial blood from systemic collaterals (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58009 graphicRef65644 graphicRef77417 \" href=\"UTD.htm?6/41/6810\">",
"     image 25A-C",
"    </a>",
"    ). Collateral vessels may include bronchial arteries, intercostal arteries, coronary arteries,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a patent ductus arteriosus. The pleura may thicken due to systemic collateral vessels and rib notching may exist. These intercostal collateral artery branches anastomose with the peripheral pulmonary artery branches via pleural adhesions. The right pulmonary artery is most frequently involved [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Anomalous origin of the left pulmonary artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the left pulmonary artery originates from the right pulmonary artery (ie, pulmonary artery sling), it reaches the left hilum by passing anterior to the right mainstem bronchus and then between the trachea and esophagus. On a chest radiograph, the aberrant left pulmonary artery can appear as a right paratracheal or retrotracheal mass, while the left hilum appears smaller and more caudal than usual. A CT scan or magnetic resonance angiogram (MRA) can directly image the anomaly (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66589 \" href=\"UTD.htm?43/18/44325\">",
"     image 26",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Anomalous pulmonary venous drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anomalous pulmonary venous drainage exists when oxygenated pulmonary venous blood drains into a vertical vein (that flows into the left brachiocephalic vein), the superior vena cava, the right atrium, the inferior vena cava, or the hepatic veins, instead of the left atrium. The aberrant venous return may involve all four pulmonary veins (ie, total) or only some of the pulmonary veins (ie, partial)",
"   </p>",
"   <p>",
"    Radiographically, the cardiac silhouette is enlarged (due to right atrial and right ventricular enlargement resulting from the left-to-right shunt) and the central and peripheral pulmonary vessels are dilated if the pulmonary venous return is not completely obstructed. In contrast, the cardiac silhouette is normal with signs of interstitial edema (thickening of interlobular septa, peribronchial cuffing, thickening of interlobar fissures) if the pulmonary venous return is completely obstructed.",
"   </p>",
"   <p>",
"    Among those patients whose pulmonary venous blood drains into a vertical vein, the anomalous vertical vein can be mistaken for a left superior vena cava. Among those patients whose pulmonary venous blood drains into the inferior vena cava, the anomalous vein can look like a scimitar along the right heart border in the right lower lung region. In cases of partial anomalous pulmonary venous return from the right upper lobe to the superior vena cava, the anomalous veins produce a configuration that is described as the &ldquo;pineapple sign&rdquo; on CT. In cases of total anomalous pulmonary venous return, the chest radiograph has a &ldquo;snowman&rdquo; configuration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary arteriovenous malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary arteriovenous malformations (AVMs) are abnormal connections between pulmonary arteries and pulmonary veins. They allow blood to bypass the pulmonary capillaries, which creates an extracardiac right-to-left shunt. Radiographically, pulmonary AVMs appear as round, oval, or scalloped homogeneous nodules or masses with feeding arteries and draining veins. They are most common in the lower lobes and in the periphery of the lung (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81070 graphicRef72468 graphicRef62261 graphicRef72937 \" href=\"UTD.htm?4/26/4522\">",
"     image 27A-D",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53034 graphicRef63749 \" href=\"UTD.htm?5/6/5224\">",
"     image 28A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50043 graphicRef57719 graphicRef64406 graphicRef77195 \" href=\"UTD.htm?32/13/32986\">",
"     image 29A-D",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62853 \" href=\"UTD.htm?4/42/4772\">",
"     image 30",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77653 \" href=\"UTD.htm?8/30/8676\">",
"     image 31",
"    </a>",
"    ). It is important to measure the diameter of the feeding artery, since embolization of the arteriovenous malformation is possible only if the diameter exceeds 3 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary AVMs are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link\">",
"     \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Diagnostic evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cystic hygroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic hygromas (ie, lymphangiomas) are an abnormal collection of lymphatic vessels. They frequently dilate, collect lymph, and resemble liquid-filled cysts. Most are located in the neck, but they can also exist in the axilla and mediastinum. Isolated mediastinal cystic hygromas are rare.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) is the best way to evaluate a suspected cystic hygroma. Characteristics include hyperintensity on T2 images, only slightly increased intensity on T1 images, and an absence of enhancement with gadolinium contrast material. CT scans demonstrate solitary or multiple liquid-filled cysts with rare interspersed calcifications and occasional enhancement of septa. Chest radiographs usually demonstrate a soft tissue mass (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50078 \" href=\"UTD.htm?39/22/40303\">",
"     image 32",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76171 graphicRef65973 \" href=\"UTD.htm?8/22/8549\">",
"     image 33A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73665 graphicRef58071 \" href=\"UTD.htm?36/27/37299\">",
"     image 34A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55203 graphicRef52563 \" href=\"UTD.htm?11/33/11798\">",
"     image 35A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63237 \" href=\"UTD.htm?29/63/30707\">",
"     image 36",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64341 graphicRef69861 \" href=\"UTD.htm?18/13/18644\">",
"     image 37A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75000 \" href=\"UTD.htm?32/18/33059\">",
"     image 38",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COMBINED ANOMALIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined pulmonary and vascular malformations (ie, hybrid abnormalities) include hypogenetic lung syndrome and bronchopulmonary sequestrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hypogenetic lung syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogenetic lung syndrome (ie, congenital venolobar syndrome, scimitar syndrome) is characterized by a small lung, ipsilateral hypoplastic pulmonary artery, and partial anomalous pulmonary venous return. The aberrant pulmonary vein (ie, the scimitar vein) usually drains to the inferior vena cava, but can also connect to the hepatic veins, portal veins, coronary sinus, or right atrium [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The bronchial tree can be a mirror image of the left side (left isomerism). Coexisting congenital cardiac anomalies are common, as well as scoliosis and hemivertebrae.",
"   </p>",
"   <p>",
"    Radiographic features include a small hyperlucent lung, an abnormal arrangement of pulmonary arteries, and an aberrant pulmonary vein coursing towards the inferior vena cava (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60621 \" href=\"UTD.htm?26/25/27026\">",
"     image 39",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73397 graphicRef53382 \" href=\"UTD.htm?1/37/1623\">",
"     image 40A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bronchopulmonary sequestration",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bronchopulmonary sequestration is a nonfunctioning mass of lung tissue that lacks normal communication with the tracheobronchial tree and receives its arterial blood supply from the systemic circulation (",
"    <a class=\"graphic graphic_picture graphicRef59835 \" href=\"UTD.htm?12/3/12343\">",
"     picture 1",
"    </a>",
"    ). The systemic arterial supply typically originates from the lower thoracic aorta, the upper abdominal aorta, or major aortic branches [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30487/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29144?source=see_link\">",
"     \"Bronchopulmonary sequestration\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sequestrations are classified anatomically as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intralobar sequestration (also known as intrapulmonary sequestration) &ndash; The lesion is located within a normal lobe, lacks its own visceral pleura, and lacks connection to the bronchial tree",
"     </li>",
"     <li>",
"      Extralobar sequestration (also known as extrapulmonary sequestration) &ndash; The mass is located outside the normal lung, has its own visceral pleura, and lacks connection to the bronchial tree",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both have a predilection for the lower lobes, especially the left lower lobe. Venous drainage from an intralobar sequestration is typically into the pulmonary veins and left atrium. In contrast, venous drainage from an extralobar sequestration is typically to systemic veins like the azygos vein, the superior vena cava, the inferior vena cava, the right atrium, or, rarely, the portal vein.",
"   </p>",
"   <p>",
"    The radiographic appearance of a sequestration is variable and relates to its stage when imaged. Sequestrations initially appear as solid masses since they do not communicate with the bronchial tree. Absent drainage of secretions and recurrent infection eventually lead to communication with the adjacent airways, particularly with intralobar, intrapulmonary sequestrations that are not protected by their own pleural cover. At this stage, the sequestration appears as a gas-containing multiloculated cystic structure, with or without gas-liquid levels (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55015 graphicRef66166 graphicRef63685 graphicRef73428 \" href=\"UTD.htm?23/11/23738\">",
"     image 41A-D",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76571 graphicRef74913 \" href=\"UTD.htm?22/24/22919\">",
"     image 42A-B",
"    </a>",
"    ). Thus, the appearance of gas or gas-liquid levels in a sequestration suggests infection.",
"   </p>",
"   <p>",
"    Conventional CT does not consistently demonstrate the aberrant systemic arterial supply. Contrast-enhanced helical CT or multidetector row CT angiography has improved the likelihood of simultaneous visualization of the arterial supply, venous drainage, and lung parenchyma. MRI can demonstrate the location of the lesion and define the aberrant arterial and venous drainage, especially if gadolinium enhanced three-dimensional MR angiography is used. A catheter aortogram is an invasive means of defining the arterial blood supply (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53449 \" href=\"UTD.htm?31/54/32609\">",
"     image 43",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Bronchopulmonary sequestrations are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29144?source=see_link\">",
"     \"Bronchopulmonary sequestration\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Developmental anomalies of the lung can be categorized as bronchopulmonary anomalies, vascular anomalies, or combined (hybrid) anomalies. They are primarily due to aberrant intrauterine development; abnormalities during postnatal lung development are uncommon. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bronchopulmonary anomalies include agenesis, congenital bronchial atresia, congenital lobar emphysema (more appropriately called congenital lobar hyperinflation), congenital pulmonary airway malformation (previously called congenital cystic adenomatoid malformation), a bronchogenic cyst, a tracheal bronchus (ie, &ldquo;pig bronchus&rdquo;), a tracheal diverticulum, and an accessory cardiac bronchus. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Bronchopulmonary anomalies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary vascular anomalies include proximal interruption of a central pulmonary artery, an anomalous origin of the left pulmonary artery from the right pulmonary artery, partial or total anomalous pulmonary venous return, pulmonary arteriovenous malformation, and maldevelopment of lymphatic vessels, such as cystic hygroma. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Vascular anomalies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Combined (hybrid) pulmonary and vascular malformations include hypogenetic lung syndrome and bronchopulmonary sequestrations. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Combined anomalies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/1\">",
"      Zylak CJ, Eyler WR, Spizarny DL, Stone CH. Developmental lung anomalies in the adult: radiologic-pathologic correlation. Radiographics 2002; 22 Spec No:S25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/2\">",
"      Mata JM, C&aacute;ceres J, Lucaya J, Garc&iacute;a-Conesa JA. CT of congenital malformations of the lung. Radiographics 1990; 10:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/3\">",
"      Lee EY, Boiselle PM, Cleveland RH. Multidetector CT evaluation of congenital lung anomalies. Radiology 2008; 247:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/4\">",
"      Jederlinic PJ, Sicilian LS, Baigelman W, Gaensler EA. Congenital bronchial atresia. A report of 4 cases and a review of the literature. Medicine (Baltimore) 1987; 66:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/5\">",
"      Kennedy CD, Habibi P, Matthew DJ, Gordon I. Lobar emphysema: long-term imaging follow-up. Radiology 1991; 180:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/6\">",
"      Patz EF Jr, M&uuml;ller NL, Swensen SJ, Dodd LG. Congenital cystic adenomatoid malformation in adults: CT findings. J Comput Assist Tomogr 1995; 19:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/7\">",
"      McGuinness G, Naidich DP, Garay SM, et al. Accessory cardiac bronchus: CT features and clinical significance. Radiology 1993; 189:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/8\">",
"      Bouros D, Pare P, Panagou P, et al. The varied manifestation of pulmonary artery agenesis in adulthood. Chest 1995; 108:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/9\">",
"      Poole PS, Ferguson EC. Revisiting pulmonary arteriovenous malformations: radiographic and CT imaging findings and corresponding treatment options. Contemporary Diagnostic Radiology 2010; 33:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/10\">",
"      Woodring JH, Howard TA, Kanga JF. Congenital pulmonary venolobar syndrome revisited. Radiographics 1994; 14:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/11\">",
"      Konen E, Raviv-Zilka L, Cohen RA, et al. Congenital pulmonary venolobar syndrome: spectrum of helical CT findings with emphasis on computerized reformatting. Radiographics 2003; 23:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/12\">",
"      Rosado-de-Christenson ML, Frazier AA, Stocker JT, Templeton PA. From the archives of the AFIP. Extralobar sequestration: radiologic-pathologic correlation. Radiographics 1993; 13:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30487/abstract/13\">",
"      Stocker JT. Sequestrations of the lung. Semin Diagn Pathol 1986; 3:106.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6980 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-6DBE490E2D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30487=[""].join("\n");
var outline_f29_49_30487=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BRONCHOPULMONARY ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Agenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Congenital bronchial atresia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Congenital lobar emphysema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Congenital pulmonary airway malformation (CPAM)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bronchogenic cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tracheal bronchus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Tracheal diverticulum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Accessory cardiac bronchus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      VASCULAR ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Proximal interruption of a central pulmonary artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Anomalous origin of the left pulmonary artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Anomalous pulmonary venous drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary arteriovenous malformations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cystic hygroma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COMBINED ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hypogenetic lung syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bronchopulmonary sequestration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6980\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6980|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/55/20338\" title=\"diagnostic image 1\">",
"      Agenesis right lung",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/62/12258\" title=\"diagnostic image 2\">",
"      Agenesis left lung",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/32/16897\" title=\"diagnostic image 3A\">",
"      Bronchial atresia CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/51/12082\" title=\"diagnostic image 3B\">",
"      Bronch atresia bronchogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/55/12159\" title=\"diagnostic image 4\">",
"      Bronchial atresia CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/34/26145\" title=\"diagnostic image 5A\">",
"      Bronchial atresia CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/60/39887\" title=\"diagnostic image 5B\">",
"      Bronchial atresia CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/1/44062\" title=\"diagnostic image 5C\">",
"      Bronchial atresia CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/44/26305\" title=\"diagnostic image 6\">",
"      Congenital emphysema right",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/27/28080\" title=\"diagnostic image 7\">",
"      Congenital emphysema left",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/31/6655\" title=\"diagnostic image 8\">",
"      Congenital emphysema CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/1/40977\" title=\"diagnostic image 9A\">",
"      Adenomatoid malform CXR I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/21/24913\" title=\"diagnostic image 9B\">",
"      Adenomatoid malform CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/7/15473\" title=\"diagnostic image 10\">",
"      Adenomatoid malform CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/9/14480\" title=\"diagnostic image 11\">",
"      Adenomatoid malform CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/47/29425\" title=\"diagnostic image 12A\">",
"      Adenomatoid malform CXR III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/9/10384\" title=\"diagnostic image 12B\">",
"      Adenomatoid malform CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/46/43745\" title=\"diagnostic image 13A\">",
"      Med bronchogen cyst CXR I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/55/25471\" title=\"diagnostic image 13B\">",
"      Med bronchogen cyst CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/32/9731\" title=\"diagnostic image 14A\">",
"      Med bronchogen cyst CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/10/3234\" title=\"diagnostic image 14B\">",
"      Med bronchogen cyst CXR III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/48/15105\" title=\"diagnostic image 14C\">",
"      Med bronchogen cyst CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/57/29585\" title=\"diagnostic image 15A\">",
"      Med bronchogen cyst CXR IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/47/38655\" title=\"diagnostic image 15B\">",
"      Med bronchogenic cyst MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/62/4064\" title=\"diagnostic image 15C\">",
"      Med bronchogen cyst CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/34/16930\" title=\"diagnostic image 16A\">",
"      Med bronchogen cyst CXR V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/39/20095\" title=\"diagnostic image 16B\">",
"      Med bronchogen cyst CT IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/30/29154\" title=\"diagnostic image 17A\">",
"      Med bronchogen cyst CXR VI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/37/12880\" title=\"diagnostic image 17B\">",
"      Med bronchogen cyst CT V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/54/28514\" title=\"diagnostic image 18\">",
"      Pulm bronchogenic cyst CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/15/6385\" title=\"diagnostic image 19\">",
"      Pulm bronchogen cyst CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/8/32911\" title=\"diagnostic image 20\">",
"      Pulm bronchogen cyst CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/53/3921\" title=\"diagnostic image 21\">",
"      Tracheal bronchus I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/21/7519\" title=\"diagnostic image 22\">",
"      Tracheal bronchus II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/29/16863\" title=\"diagnostic image 23\">",
"      Tracheal diverticulum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/51/20272\" title=\"diagnostic image 24\">",
"      Cardiac bronchus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/47/23281\" title=\"diagnostic image 25A\">",
"      Proximal PA interrupt I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/18/17697\" title=\"diagnostic image 25B\">",
"      Proximal PA interrupt II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/0/22533\" title=\"diagnostic image 25C\">",
"      Proximal PA interrupt III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/18/44325\" title=\"diagnostic image 26\">",
"      PA sling CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/12/193\" title=\"diagnostic image 27A\">",
"      Pulm AVM Brain CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/22/21857\" title=\"diagnostic image 27B\">",
"      Pulm AVM CXR I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/40/641\" title=\"diagnostic image 27C\">",
"      Pulm AVM CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/6/7264\" title=\"diagnostic image 27D\">",
"      Pulm AVM CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/23/1395\" title=\"diagnostic image 28A\">",
"      Pulm AVM CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/35/42546\" title=\"diagnostic image 28B\">",
"      Pulm AVM CT IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/18/18722\" title=\"diagnostic image 29A\">",
"      Pulm AVM CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/27/40369\" title=\"diagnostic image 29B\">",
"      Pulm AVM PA gram III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/20/42306\" title=\"diagnostic image 29C\">",
"      Pulm AVM PA gram IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/15/24819\" title=\"diagnostic image 29D\">",
"      Pulm AVM PA gram V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/42/4772\" title=\"diagnostic image 30\">",
"      Pulm AVM PA gram I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/30/8676\" title=\"diagnostic image 31\">",
"      Pulm AVM PA gram II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/22/40303\" title=\"diagnostic image 32\">",
"      Cystic hygroma CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/27/17841\" title=\"diagnostic image 33A\">",
"      Cystic hygroma CXR I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/30/24047\" title=\"diagnostic image 33B\">",
"      Cystic hygroma CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/21/26975\" title=\"diagnostic image 34A\">",
"      Cystic hygroma CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/47/752\" title=\"diagnostic image 34B\">",
"      Cystic hygroma MRI I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/9/11410\" title=\"diagnostic image 35A\">",
"      Cystic hygroma CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/5/44127\" title=\"diagnostic image 35B\">",
"      Cystic hygroma CT IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/63/30707\" title=\"diagnostic image 36\">",
"      Cystic hygroma CXR III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/14/38127\" title=\"diagnostic image 37A\">",
"      Cystic hygroma CT V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/3/9264\" title=\"diagnostic image 37B\">",
"      Cystic hygroma MRI II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/18/33059\" title=\"diagnostic image 38\">",
"      Cystic hygroma CXR IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/25/27026\" title=\"diagnostic image 39\">",
"      Scimitar syndrome I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/16/8450\" title=\"diagnostic image 40A\">",
"      Scimitar syndrome II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/32/11777\" title=\"diagnostic image 40B\">",
"      Scimitar syndrome III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/23/8562\" title=\"diagnostic image 41A\">",
"      Sequestration CXR I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/31/24048\" title=\"diagnostic image 41B\">",
"      Sequestration CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/7/11377\" title=\"diagnostic image 41C\">",
"      Sequestration CXR II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/63/14323\" title=\"diagnostic image 41D\">",
"      Sequestration aortogram I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/12/17602\" title=\"diagnostic image 42A\">",
"      Sequestration CXR III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/19/4402\" title=\"diagnostic image 42B\">",
"      Sequestration CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/54/32609\" title=\"diagnostic image 43\">",
"      Sequestration aortogram II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6980|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/3/12343\" title=\"picture 1\">",
"      Lobectomy specimen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29144?source=related_link\">",
"      Bronchopulmonary sequestration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/11/44214?source=related_link\">",
"      Congenital lobar emphysema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/50/810?source=related_link\">",
"      Congenital pulmonary airway (cystic adenomatoid) malformation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=related_link\">",
"      Pulmonary arteriovenous malformations: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30488="Clinical manifestations and diagnosis of psoriatic arthritis";
var content_f29_49_30488=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of psoriatic arthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Dafna D Gladman, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Christopher Ritchlin, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Joachim Sieper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30488/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/49/30488/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriatic arthritis is an inflammatory arthritis associated with psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/1\">",
"     1",
"    </a>",
"    ]. Although initially considered a variant of rheumatoid arthritis, psoriatic arthritis emerged as a distinct clinical entity [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/2\">",
"     2",
"    </a>",
"    ]. In the past, seronegativity for rheumatoid factor has been a requirement for the diagnosis. However, over 10 percent of patients with uncomplicated psoriasis and up to 15 percent of the normal population have rheumatoid factor present in their serum. As a result, the term &ldquo;usually seronegative&rdquo; arthritis is most suitable for psoriatic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of psoriatic arthritis are discussed here. The pathogenesis and treatment of this disorder are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23608?source=see_link\">",
"     \"Pathogenesis of psoriatic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40234?source=see_link\">",
"     \"Treatment of psoriatic arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriatic arthritis (PsA) affects women and men equally, with an incidence of approximately 6 per 100,000 per year and a prevalence of about 1 to 2 per 1000 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/1,3,5-8\">",
"     1,3,5-8",
"    </a>",
"    ]. A 2008 systematic review of reports from 1987 to 2006 found marked variability of the reported incidence and prevalence estimates in the general population and suggested that different definitions, as well as geography, may contribute to the variability [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the same limitations, estimates of the prevalence of psoriatic arthritis among patients with psoriasis have ranged from 4 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/8,10,11\">",
"     8,10,11",
"    </a>",
"    ]. A multicenter trial in Europe of 1560 patients with psoriasis estimated that 31 percent of the patients would have psoriatic arthritis after 30 years of psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/12\">",
"     12",
"    </a>",
"    ]. In this study, the risk of developing psoriatic arthritis did not decrease with time. Another study of 1511 patients with psoriasis from academic and community dermatology practices in Germany identified 21 percent of the patients as having psoriatic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/13\">",
"     13",
"    </a>",
"    ]. Using the internationally agreed upon Classification Criteria for Psoriatic Arthritis (CASPAR) criteria that were first proposed in 2006, the estimated prevalence of PsA among patients with psoriasis in two large general practices in the United Kingdom was 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/14\">",
"     14",
"    </a>",
"    ]. A prospective four-year study of patients with psoriasis who did not have psoriatic arthritis at presentation found an incidence of newly diagnosed psoriatic arthritis, also based upon the CASPAR criteria, of almost 2 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Classification criteria'",
"    </a>",
"    below.) The severity of psoriasis, the presence of nail lesions, and the presence of scalp and intergluteal lesions were more likely to occur in those with psoriatic arthritis.",
"   </p>",
"   <p>",
"    Among patients presenting with previously undiagnosed arthritis, psoriatic arthritis is present in a small minority. As an example, in one prospective study of 1018 patients with &ldquo;early synovitis,&rdquo; a diagnosis of psoriatic arthritis was made in 129 patients (13 percent), a minority of whom (6 percent) did not have psoriasis at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of psoriatic arthritis is dependent upon both clinical and radiological observations. The presence of an inflammatory arthritis in a patient with psoriasis makes the diagnosis likely. However, not all patients with psoriasis and arthritis have psoriatic arthritis. As an example, patients with psoriasis may have coexistent rheumatoid arthritis, osteoarthritis, arthritis of inflammatory bowel disease, and gout. Thus, the following clinical and radiographic features are often required to establish the correct diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with psoriatic arthritis present with pain and stiffness in the affected joints. Morning stiffness lasting more than 30 minutes occurs in one-half of patients. The stiffness is accentuated with prolonged immobility and is alleviated by physical activity.",
"   </p>",
"   <p>",
"    On physical examination, stress pain, joint line tenderness, and effusions in the affected joints are present, often in an asymmetric distribution [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The distal interphalangeal joints and spine are each affected in 40 to 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with psoriatic arthritis tend to be less tender than patients with other inflammatory arthritides such as rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/19\">",
"     19",
"    </a>",
"    ]. As a result, they may present with joint deformity without a significant degree of pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Patterns of arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several clinical patterns of joint involvement in psoriatic arthritis have been identified:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Distal arthritis, characterized by involvement of the distal interphalangeal (DIP) joints (",
"      <a class=\"graphic graphic_picture graphicRef70503 graphicRef79872 \" href=\"UTD.htm?23/18/23844\">",
"       picture 1A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Asymmetric oligoarthritis, in which less than five small",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      large joints are affected in an asymmetric distribution",
"     </li>",
"     <li>",
"      Symmetric polyarthritis, similar to and, at times, indistinguishable from rheumatoid arthritis (RA)",
"     </li>",
"     <li>",
"      Arthritis mutilans, characterized by deforming and destructive arthritis (",
"      <a class=\"graphic graphic_picture graphicRef51683 \" href=\"UTD.htm?19/59/20400\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58184 \" href=\"UTD.htm?10/36/10831\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Spondyloarthritis, including both sacroiliitis and spondylitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This classification was described by Moll and Wright, who noted that most of their patients had an oligoarticular presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/2\">",
"     2",
"    </a>",
"    ]. However, subsequent studies have not found the same distribution in all patient populations [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/20\">",
"     20",
"    </a>",
"    ]. Furthermore, some patients present with more than one pattern, and many change the pattern of their arthritis during follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Therefore, most investigators consider psoriatic arthritis as involving peripheral joints, axial joints, or axial and peripheral joints. Axial involvement alone occurs in 2 to 4 percent of patients with psoriatic arthritis.",
"   </p>",
"   <p>",
"    Thus, while distal arthritis and arthritis mutilans are considered most specific for psoriatic arthritis, they are not the most common patterns seen [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/5,20\">",
"     5,20",
"    </a>",
"    ]. The most frequent presentations are polyarthritis, followed by oligoarthritis. Distal involvement alone occurs in less than 20 percent of cases and may be associated with spondyloarthritis. On the other hand, arthritis mutilans can occur with any of the patterns. The spondyloarthritis is usually found in association with peripheral joint involvement and rarely occurs alone.",
"   </p>",
"   <p>",
"    Other common rheumatic features of psoriatic arthritis include soft tissue inflammation similar to that seen in other seronegative arthritides:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enthesitis &mdash; Enthesitis (inflammation at the site of tendon insertion into bone) of the Achilles tendon, the plantar fascia, and the pelvic bones. Subclinical Achilles tendinitis, detected ultrasonographically, is more common in those with psoriasis than in healthy persons [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Assessment tools for enthesitis have been developed. While some work better in enthesitis of ankylosing spondylitis, others work better for psoriatic arthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tenosynovitis &mdash; Tenosynovitis of the flexor tendons of the hands, of the extensor carpi ulnaris, or at other sites",
"     </li>",
"     <li>",
"      Dactylitis &mdash; Dactylitis, characterized by diffuse swelling of an entire finger or toe, often termed a &ldquo;sausage digit.&rdquo; Dactylitis is defined as uniform swelling of the soft tissues between the metacarpophalangeal and interphalangeal joints, such that the digital tufts are swollen diffusely. In dactylitis, joint swelling, which may be present, can no longer be recognized independently [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/27\">",
"       27",
"      </a>",
"      ]. Sausage digits occur in nearly one-half of patients with psoriatic arthritis and are associated with an increased risk of progressive radiographic joint damage [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/28\">",
"       28",
"      </a>",
"      ]. This abnormality is thought to result from inflammation of soft tissues, including the tendon sheaths, and from the concomitant inflammation of the adjacent joints [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/29\">",
"       29",
"      </a>",
"      ]. This finding is suggestive of psoriatic arthritis (",
"      <a class=\"graphic graphic_picture graphicRef67123 \" href=\"UTD.htm?23/16/23809\">",
"       picture 3",
"      </a>",
"      ). A tool to measure dactylitis has been developed and has proven to be reliable and sensitive to change [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Nail lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nail pits and onycholysis that occur in psoriatic arthritis are indistinguishable from the nail lesions that occur in uncomplicated psoriasis. Characteristic features of psoriasis affecting the nail bed include nail pits, onycholysis, nail bed hyperkeratosis, and splinter hemorrhages [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pits are sharply defined depressions in the plate caused by shedding of nail plate cells. They look as if someone has taken a pin and pricked the nail several times (",
"      <a class=\"graphic graphic_picture graphicRef62855 \" href=\"UTD.htm?38/42/39599\">",
"       picture 4",
"      </a>",
"      ). Pits usually occur in large numbers and involve several nails.",
"     </li>",
"     <li>",
"      Onycholysis, or separation of the nail from its bed, may involve the whole or only part of the nail. This change occasionally has to be differentiated from a fungal infection by sending nail scrapings for fungal cultures.",
"     </li>",
"     <li>",
"      Other lesions include leukonychia (Mees&rsquo; lines), red spots in the lunula, and nail plate crumbling [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the extent of skin disease, in general, has not correlated with the degree of joint disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/32\">",
"     32",
"    </a>",
"    ], the severity of psoriatic nail involvement correlates closely with the extent and severity of both skin and joint disease and is more common in those with distal interphalangeal arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/33\">",
"     33",
"    </a>",
"    ]. A nail psoriasis severity index has been developed, modified, and validated [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/31\">",
"     31",
"    </a>",
"    ]. Nail involvement correlated with many clinical features of psoriatic arthritis, such as global severity and the number of tender or swollen joints [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pitting edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Swelling of the hands or feet with pitting edema is sometimes a presenting feature of psoriatic arthritis. This was illustrated by a case control study of 183 patients and 366 controls with other rheumatic disorders (excluding other spondyloarthropathies) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/34\">",
"     34",
"    </a>",
"    ]. The prevalence of pitting edema was higher in the patients (21 versus 5 percent in rheumatic disease controls, p &lt;0.0001). The edema was often asymmetrical and occasionally preceded joint involvement.",
"   </p>",
"   <p>",
"    Clinically apparent chronic lymphedema (which may be nonpitting) is a rare extraarticular manifestation of psoriatic arthritis, and lymphatic obstruction has been confirmed in some cases using lymphoscintigraphy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. However, similar symmetrical swelling of the upper extremities due to extensive tenosynovitis in the absence of impaired lymphatic function has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=see_link&amp;anchor=H802872645#H802872645\">",
"     \"Clinical manifestations and diagnosis of lymphedema\", section on 'Inflammatory arthritis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Ocular involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other chronic inflammatory joint disorders, particularly the spondyloarthropathies such as ankylosing spondylitis, ocular inflammation occurs in some patients with psoriatic arthritis. Uveitis, which may present insidiously with visual impairment or acutely with a painful red eye, is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=see_link&amp;anchor=H5#H5\">",
"     \"Uveitis: Etiology, clinical manifestations, and diagnosis\", section on 'Systemic inflammatory diseases associated with uveitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Relation between arthritis and skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, patients with psoriatic arthritis must have evidence of psoriasis. The arthritis appears after the onset of skin lesions in the majority of patients, simplifying the diagnosis. However, the arthritis precedes the skin disease in approximately 13 to 17 percent of cases, and skin lesions are present but have not been diagnosed in an additional 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this setting, certain clinical features suggest the presence of psoriatic arthritis in the absence of psoriasis (psoriatic arthritis sine psoriasis):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Distal joint involvement",
"     </li>",
"     <li>",
"      Asymmetric distribution",
"     </li>",
"     <li>",
"      The possible presence of nail lesions (onycholysis) or hidden psoriatic plaques",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following have also been suggested as helpful in identifying those with psoriatic arthritis sine psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dactylitis",
"     </li>",
"     <li>",
"      Family history of psoriasis",
"     </li>",
"     <li>",
"      Presence of human leukocyte antigen (HLA)-Cw6",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nail lesions may help to identify those patients with psoriasis who are at higher risk of developing arthritis. These lesions occur in 80 to 90 percent of patients with psoriatic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/4,32\">",
"     4,32",
"    </a>",
"    ], compared with 46 percent of those with psoriasis uncomplicated by arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies suggest that psoriatic arthritis occurs more commonly among patients with severe psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3,11,38\">",
"     3,11,38",
"    </a>",
"    ]. However, a minority of patients note a relationship between the activity of the skin and joint manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. As an example, many patients with severe psoriatic arthritis have few skin manifestations; other patients present with severe skin psoriasis and have either no joint disease or only minimal joint inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiologic changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of radiologic changes early in the course of psoriatic arthritis suggests either very aggressive disease or arthritis of longer duration than that reported by the patient. Radiological damage was observed in two-thirds of patients at their first visit to our psoriatic arthritis clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3\">",
"     3",
"    </a>",
"    ]. The most striking radiologic feature is the coexistence of erosive changes and new bone formation in the distal joints; other typical radiological changes include lysis of the terminal phalanges; fluffy periostitis, as well as new bone formation, at the site of enthesitis; gross destruction of isolated joints; &ldquo;pencil-in-cup&rdquo; appearance; and the occurrence of both joint lysis and ankylosis in the same patient (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58709 \" href=\"UTD.htm?18/29/18911\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/3,39\">",
"     3,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) may be more sensitive than routine radiography in detecting articular, periarticular, and soft-tissue inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Using MRI, distinct abnormalities characterized by marked inflammation in the adjacent bone marrow and soft tissues, combined with the detection of inflammation of entheses in joints felt to be clinically not inflamed, suggest that enthesitis is the primary lesion in psoriatic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/42\">",
"     42",
"    </a>",
"    ]. While MRI findings suggestive of moderate to severe sacroiliitis are found in more than one-third of patients, these imaging findings are poor predictors of clinical symptoms; MRI evidence of sacroiliitis does correlate with decreased spinal mobility and with longer duration of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psoriatic arthritis is associated with a decrease in bone mineral density; this may lead to osteoporosis and to an increased risk of fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no diagnostic laboratory tests in psoriatic arthritis. An elevated sedimentation rate and leukocytosis are seen in about one-third of patients, reflecting a nonspecific inflammatory response. Anemia can be induced either by the chronic disease or by iron deficiency resulting from prolonged use of antiinflammatory medications.",
"   </p>",
"   <p>",
"    Rheumatoid factor (RF) is found in 2 to 10 percent of patients with psoriatic arthritis. Antinuclear antibodies (ANA) are found at low titer",
"    <span class=\"nowrap\">",
"     (&ge;1/40)",
"    </span>",
"    in nearly 50 percent and at clinically significant titers",
"    <span class=\"nowrap\">",
"     (&ge;1/80)",
"    </span>",
"    in 14 percent, and anti-double-stranded DNA is found in 3 percent of patients with psoriatic arthritis in the absence of exposure to anti-tumor necrosis factor (TNF)-alpha antibodies or other anti-TNF therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/45\">",
"     45",
"    </a>",
"    ]. Both RF and ANA also occur in patients with psoriasis uncomplicated by arthritis and may reflect the immunologic response in this disease.",
"   </p>",
"   <p>",
"    Antibodies to citrullinated proteins (eg, anticyclic citrullinated peptide [anti-CCP]), which are also associated with rheumatoid arthritis, have been found in 8 to 16 percent of patients with psoriatic arthritis and are most frequently found in the serum of those with erosive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    polyarticular disease, but they may be present in those with severe psoriasis in the absence of arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/46-49\">",
"     46-49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriatic arthritis can simulate the findings in other arthritides (",
"    <a class=\"graphic graphic_table graphicRef72238 \" href=\"UTD.htm?23/7/23676\">",
"     table 1",
"    </a>",
"    ). As an example, asymmetric oligoarthritis, enthesitis, sausage digits, and back pain also can be seen in reactive arthritis (formerly called Reiter syndrome). However, genitourinary lesions, the characteristic skin lesions that are different from psoriasis, and typical HLA-B27 positivity usually permit the diagnosis of reactive arthritis to be made. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, the patient who presents with polyarthritis can simulate rheumatoid arthritis. However, involvement of the DIP joints, an asymmetric distribution of joint disease, spondyloarthritis, sausage digits, new bone formation on radiographs, cutaneous findings, and the characteristic nail manifestations of psoriatic arthritis all help to distinguish psoriatic arthritis from rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spinal disease that occurs in patients with psoriatic arthritis may be difficult to distinguish from ankylosing spondylitis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. However, some radiographic features may help distinguish the two disorders. Psoriatic arthritis is more often associated with the presences of asymmetric sacroiliitis, non-marginal syndesmophytes, asymmetric syndesmophytes, more frequent involvement of the cervical spine, and less frequent involvement of the lumbar spine.",
"   </p>",
"   <p>",
"    Psoriatic arthritis and gout can coexist. Thus, gouty arthritis should be excluded before the diagnosis of psoriatic arthritis is made in a patient with psoriasis and acute monoarthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLASSIFICATION CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Criteria that can be used to classify a patient as having psoriatic arthritis are valuable in scientific communication and in clinical trials. Until 2006, there had been no generally agreed-upon set of classification criteria for psoriatic arthritis. An international study of proposed criteria, the Classification of Psoriatic Arthritis (CASPAR) study, included 588 patients with psoriatic arthritis and 536 patients with other forms of inflammatory arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CASPAR study concluded that a patient with an inflammatory musculoskeletal disease (peripheral arthritis, spondylitis, or enthesitis) can be classified as having psoriatic arthritis if a total of at least three points is accumulated from the presence of the following list of features (each of which is assigned a certain number of points):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Skin psoriasis that is:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Present &mdash; two points, OR",
"     </li>",
"     <li>",
"      Previously present by history &mdash; one point, OR",
"     </li>",
"     <li>",
"      A family history of psoriasis, if the patient is not affected &mdash; one point",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nail lesions (onycholysis, pitting) &mdash; one point",
"     </li>",
"     <li>",
"      Dactylitis (present or past, documented by a rheumatologist) &mdash; one point",
"     </li>",
"     <li>",
"      Negative rheumatoid factor &mdash; one point",
"     </li>",
"     <li>",
"      Juxtaarticular bone formation on radiographs (distinct from osteophytes) &mdash; one point",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These classification criteria should facilitate studies in psoriatic arthritis and may function well in diagnosing psoriatic arthritis, given sensitivity and specificity in four studies, including two of early arthritis patients, ranging from 91 to 100 percent and from 97 to 99 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/52-56\">",
"     52-56",
"    </a>",
"    ]. However, these criteria can only be applied to individuals who demonstrate evidence for inflammatory musculoskeletal disease (peripheral arthritis, axial disease, or enthesitis).",
"   </p>",
"   <p>",
"    A number of screening questionnaires have been developed to identify patients with psoriatic arthritis in dermatology or general practice [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/57\">",
"     57",
"    </a>",
"    ]. Several were developed to identify psoriatic arthritis among patients with psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/58-61\">",
"     58-61",
"    </a>",
"    ], while the Toronto Psoriatic Arthritis Screen (ToPAS) was developed to identify patients with psoriatic arthritis regardless of the setting [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30488/abstract/62\">",
"     62",
"    </a>",
"    ]. These instruments are similar in terms of sensitivity and specificity and should be used to identify patients who should be seen by a rheumatologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/52/835?source=see_link\">",
"       \"Patient information: Psoriatic arthritis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"       \"Patient information: Psoriatic arthritis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of psoriatic arthritis should be considered in a patient with psoriasis who develops arthritis or in a patient with the typical clinical features of psoriatic arthritis, including both distal and axial involvement. In the latter setting, hidden psoriatic lesions should be sought if there is no overt evidence or history of psoriasis. In less clear cases, psoriatic arthritis must be differentiated from other disorders such as reactive arthritis (formerly Reiter syndrome) and rheumatoid arthritis (",
"    <a class=\"graphic graphic_table graphicRef72238 \" href=\"UTD.htm?23/7/23676\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/1\">",
"      Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs 2002; 62:2447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/2\">",
"      Wright V, Moll JM. Psoriatic arthritis. Bull Rheum Dis 1971; 21:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/3\">",
"      Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA)--an analysis of 220 patients. Q J Med 1987; 62:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/4\">",
"      Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986; 13:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/5\">",
"      Gladman DD. Current concepts in psoriatic arthritis. Curr Opin Rheumatol 2002; 14:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/6\">",
"      Madland TM, Apalset EM, Johannessen AE, et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005; 32:1918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/7\">",
"      Salvarani C, Olivieri I, Cantini F, et al. Psoriatic arthritis. Curr Opin Rheumatol 1998; 10:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/8\">",
"      Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/9\">",
"      Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008; 35:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/10\">",
"      Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003; 4:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/11\">",
"      Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/12\">",
"      Christophers E, Barker JN, Griffiths CE, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010; 24:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/13\">",
"      Reich K, Kr&uuml;ger K, M&ouml;ssner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/14\">",
"      Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/15\">",
"      Eder L, Chandran V, Shen H, et al. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) 2011; 63:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/16\">",
"      Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/17\">",
"      Gladman DD, Farewell V, Buskila D, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990; 17:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/18\">",
"      Oriente P, Biondi-Oriente C, Scarpa R. Psoriatic arthritis. Clinical manifestations. Baillieres Clin Rheumatol 1994; 8:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/19\">",
"      Buskila D, Langevitz P, Gladman DD, et al. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992; 19:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/20\">",
"      Gladman DD. Psoriatic arthritis. Baillieres Clin Rheumatol 1995; 9:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/21\">",
"      Jones SM, Armas JB, Cohen MG, et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/22\">",
"      Khan M, Schentag C, Gladman DD. Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol 2003; 30:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/23\">",
"      McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003; 42:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/24\">",
"      De Simone C, Guerriero C, Giampetruzzi AR, et al. Achilles tendinitis in psoriasis: clinical and sonographic findings. J Am Acad Dermatol 2003; 49:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/25\">",
"      Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 2008; 67:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/26\">",
"      Gladman DD, Inman RD, Cook RJ, et al. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007; 34:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/27\">",
"      Rothschild BM, Pingitore C, Eaton M. Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998; 28:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/28\">",
"      Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005; 64:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/29\">",
"      Kane D, Greaney T, Bresnihan B, et al. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999; 26:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/30\">",
"      Helliwell PS, Firth J, Ibrahim GH, et al. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005; 32:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/31\">",
"      Cassell SE, Bieber JD, Rich P, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/32\">",
"      Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 1999; 26:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/33\">",
"      Williamson L, Dalbeth N, Dockerty JL, et al. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 2004; 43:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/34\">",
"      Cantini F, Salvarani C, Olivieri I, et al. Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. Clin Exp Rheumatol 2001; 19:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/35\">",
"      Mulherin DM, FitzGerald O, Bresnihan B. Lymphedema of the upper limb in patients with psoriatic arthritis. Semin Arthritis Rheum 1993; 22:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/36\">",
"      Salvarani C, Cantini F, Olivieri I, et al. Distal extremity swelling with pitting edema in psoriatic arthritis: evidence of 2 pathological mechanisms. J Rheumatol 1999; 26:1831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/37\">",
"      Scarpa R, Cosentini E, Manguso F, et al. Clinical and genetic aspects of psoriatic arthritis \"sine psoriasis\". J Rheumatol 2003; 30:2638.",
"     </a>",
"    </li>",
"    <li>",
"     Bennet RM. Psoriatic arthritis. In: Arthritis and Related Conditions, 11th, McCarty DJ (Ed), Lea &amp; Febiger, Philadelphia 1989. p.954.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/39\">",
"      Siannis F, Farewell VT, Cook RJ, et al. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis 2006; 65:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/40\">",
"      Offidani A, Cellini A, Valeri G, Giovagnoni A. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venereol 1998; 78:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/41\">",
"      McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999; 42:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/42\">",
"      Tan AL, Grainger AJ, Tanner SF, et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum 2006; 54:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/43\">",
"      Williamson L, Dockerty JL, Dalbeth N, et al. Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford) 2004; 43:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/44\">",
"      Frediani B, Allegri A, Falsetti P, et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001; 28:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/45\">",
"      Johnson SR, Schentag CT, Gladman DD. Autoantibodies in biological agent naive patients with psoriatic arthritis. Ann Rheum Dis 2005; 64:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/46\">",
"      Bogliolo L, Alpini C, Caporali R, et al. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 2005; 32:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/47\">",
"      Vander Cruyssen B, Hoffman IE, Zmierczak H, et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005; 64:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/48\">",
"      Alenius GM, Berglin E, Rantap&auml;&auml; Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 2006; 65:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/49\">",
"      B&ouml;ckelmann R, Gollnick H, Bonnekoh B. Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis. Arthritis Rheum 2006; 54:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/50\">",
"      Turkiewicz AM, Moreland LW. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 2007; 56:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/51\">",
"      Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64 Suppl 2:ii3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/52\">",
"      Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/53\">",
"      Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007; 57:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/54\">",
"      D'Angelo S, Mennillo GA, Cutro MS, et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol 2009; 36:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/55\">",
"      Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol 2008; 35:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/56\">",
"      Coates LC, Conaghan PG, Emery P, et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2012; 64:3150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/57\">",
"      Dominguez P, Gladman DD, Helliwell P, et al. Development of screening tools to identify psoriatic arthritis. Curr Rheumatol Rep 2010; 12:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/58\">",
"      Alenius GM, Stenberg B, Stenlund H, et al. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002; 29:2577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/59\">",
"      Dominguez PL, Husni ME, Holt EW, et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009; 301:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/60\">",
"      Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009; 27:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/61\">",
"      Khraishi M, Mong J, Mugford G, Landells I. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients. J Cutan Med Surg 2011; 15:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30488/abstract/62\">",
"      Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009; 68:497.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7784 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-00FF42CD0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30488=[""].join("\n");
var outline_f29_49_30488=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Patterns of arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Nail lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pitting edema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Ocular involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Relation between arthritis and skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiologic changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLASSIFICATION CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7784\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7784|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/36/10831\" title=\"diagnostic image 1\">",
"      Mutilans in psoriasis x ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/29/18911\" title=\"diagnostic image 2\">",
"      DIP joints in psoriasis x ray",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7784|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/39/15999\" title=\"picture 1A\">",
"      DIP joints psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/35/39472\" title=\"picture 1B\">",
"      Psoriatic arthritis hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/59/20400\" title=\"picture 2\">",
"      Arthritis mutilans in psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/16/23809\" title=\"picture 3\">",
"      Psoriatic arthritis foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/42/39599\" title=\"picture 4\">",
"      Nail changes in psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7784|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/7/23676\" title=\"table 1\">",
"      Differential dx of arthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23608?source=related_link\">",
"      Pathogenesis of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=related_link\">",
"      Patient information: Psoriatic arthritis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/52/835?source=related_link\">",
"      Patient information: Psoriatic arthritis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40234?source=related_link\">",
"      Treatment of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=related_link\">",
"      Uveitis: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30489="Overview of the management of primary colon cancer";
var content_f29_49_30489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the management of primary colon cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Miguel A Rodriguez-Bigas, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Axel Grothey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/49/30489/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/49/30489/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colorectal cancer is the third most common cancer affecting both males and females in the United States; over 70 percent of cases arise in the colon [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/1\">",
"     1",
"    </a>",
"    ]. Globally, colorectal cancer is the third most commonly diagnosed cancer in males and the second in females; however, the incidence varies markedly [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/2\">",
"     2",
"    </a>",
"    ]. Country-specific incidence rates are available through the World Health Organization",
"    <a class=\"external\" href=\"file://globocan.iarc.fr/\">",
"     GLOBOCAN database",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    This topic review will provide an overview of the management and prognosis of primary colon cancer. Epidemiology, risk factors, clinical presentation, and diagnosis are addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a colon cancer is usually made by colonoscopy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17948751\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;&ldquo;Staging&rdquo; a cancer provides a standard framework for describing disease extent. The stage of a colon cancer has three components, primary tumor (T), status of the regional nodes (N), and distant metastasis (M), which together are combined to form stage groupings, from I to IV. Stage groupings permit the stratification of prognosis, which is useful for the selection of treatment. The T, N, and M categories for colon cancer are assigned based upon:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whether there are signs of cancer spread on physical examination or radiographic imaging tests",
"     </li>",
"     <li>",
"      Findings from surgical resection and histologic examination of the resected tissues",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The AJCC 7th Edition TNM staging for colorectal cancer is illustrated in the table (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ). TNM staging for colorectal cancer is discussed in more detail elsewhere, and colon cancer prognosis, stratified according to stage, is discussed in more detail below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'TNM staging'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H35\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949181\">",
"    <span class=\"h1\">",
"     THE CLINICAL STAGING EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pretreatment clinical staging is best accomplished by physical examination (with particular attention to ascites, hepatomegaly and lymphadenopathy), CT scan of the abdomen and pelvis, and chest imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical staging evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949425\">",
"    <span class=\"h2\">",
"     Radiographic imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with newly diagnosed colon cancer, preoperative abdominal and pelvic CT scans can demonstrate regional tumor extension, regional lymphatic and distant metastases, and tumor-related complications (eg, obstruction, perforation, fistula formation), findings that may assist in selecting the therapeutic approach. An important point is that the finding of isolated liver or lung metastases on preoperative studies may not necessarily alter the surgical approach to the primary tumor, particularly in patients who are symptomatic from bleeding or impending obstruction. (See",
"    <a class=\"local\" href=\"#H17948926\">",
"     'Metastatic disease'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125364929#H125364929\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Staging'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=see_link&amp;anchor=H5#H5\">",
"     \"Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer\", section on 'Management of the primary cancer in patients presenting with synchronous metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The necessity of preoperative",
"    <span class=\"nowrap\">",
"     abdominal/pelvic",
"    </span>",
"    CT for all patients with colon cancer is controversial, as is the clinical benefit of a staging chest CT. Nevertheless, the standard practice at most institutions is that all patients with stage II, III, or IV colon cancer undergo chest, abdomen and pelvic CT, either prior to or following resection, an approach that is endorsed by the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     National Comprehensive Cancer Network (NCCN)",
"    </a>",
"    and the",
"    <a class=\"external\" href=\"file://www.annonc.oxfordjournals.org/content/21/suppl_5/v70.full\">",
"     European Society of Medical Oncology (ESMO)",
"    </a>",
"    . It is generally preferable to&nbsp;obtain these scans prior to, rather than after operation, as the scan results will occasionally change&nbsp;surgical planning.",
"   </p>",
"   <p>",
"    Contrast-enhanced magnetic resonance imaging (MRI) of the liver identifies more hepatic lesions than are visualized by CT and may be indicated to further define the extent of disease in patients who have suspected liver metastases on CT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Liver MRI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PET scans do not appear to add significant information to CT scans for routine preoperative staging of colon cancer. PET scan may be helpful for patients who are thought to be candidates for resection of isolated colorectal cancer liver and lung metastases, in whom the routine use of PET reduces the number of non-therapeutic laparotomies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'PET scans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949195\">",
"    <span class=\"h2\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of tumor markers have been associated with colon cancer, especially carcinoembryonic antigen (CEA). Serum CEA levels should be obtained preoperatively in patients with colon cancer, particularly as an aid to posttreatment follow up. Elevated preoperative CEA levels that do not normalize following surgical resection imply the presence of persistent disease and the need for further evaluation. Serum CEA should",
"    <strong>",
"     NOT",
"    </strong>",
"    be used as a screening test for colon cancer due to low sensitivity and specificity for early stage disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949202\">",
"    <span class=\"h2\">",
"     Colonoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally, each patient should have visualization of the entire colon prior to surgery. Colonoscopy serves to localize the tumor, provide a tissue diagnosis, characterize the lesion as mucosal or submucosal, and evaluate for the presence of extrinsic colonic compression and synchronous carcinomas and adenomas. Synchronous invasive colorectal cancers are found in 3 to 5 percent of cases, while the prevalence of synchronous adenomas is as high as 30 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125364929#H125364929\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If full colonoscopy cannot be performed prior to elective colon resection because of obstruction or poor preparation, a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema (BE) or (preferably) CT or magnetic resonance (MR) colonography can be used to evaluate the entire large bowel. Alternatively, the entire residual colon can be examined colonoscopically after resection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Colonoscopy, BE, and CT colonography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949245\">",
"    <span class=\"h2\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family history of colorectal and other extracolonic cancers (going back three generations if possible, but at least first- and second-degree relatives) should be sought, as the patient may be a member of kindred with a hereditary predisposition. This finding could alter the surgical approach, prompting consideration of subtotal or total colectomy in high-risk individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link&amp;anchor=H16#H16\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H17950156\">",
"     'Genetic issues'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17948781\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF LOCALIZED DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Surgical resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 80 percent of cancers are localized to the colon wall",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    regional nodes. Surgery is the only curative modality for localized colon cancer. The goal of a colectomy for invasive cancer is complete removal of the tumor, the major vascular pedicle, and the lymphatic drainage basin of the affected colonic segment (",
"    <a class=\"graphic graphic_figure graphicRef64156 \" href=\"UTD.htm?13/22/13670\">",
"     figure 1",
"    </a>",
"    ). Surgical procedures for treatment of primary colon cancer are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link\">",
"     \"Surgical oncologic principles for the resection of colon cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Restoration of bowel continuity using a primary anastomosis can be accomplished in most patients undergoing an uncomplicated colectomy. However, a temporary proximal diverting colostomy may be necessary if there is diffuse peritonitis or free perforation, if the patient is medically unstable, or sometimes, for an obstructing left-sided colon cancer, although this is a controversial area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125359310#H125359310\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Obstructed'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Laparoscopic-assisted colectomy rather than open colectomy is an acceptable option for patients with non-obstructed, non-perforated, non-locally advanced colon cancers who have not had prior extensive abdominal surgery. In experienced hands, appropriately selected patients have comparable oncologic outcomes, perioperative morbidity and mortality, and faster recovery with laparoscopic as compared to open surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125359914#H125359914\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Laparoscopic colectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are reports that robotic surgery has be performed safely for colon cancer, but there are no randomized trials comparing this approach to either laparoscopic or open colonic surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H287094127#H287094127\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Robotic-assisted colectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7619375\">",
"    <span class=\"h3\">",
"     Elderly patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery for colon cancer (including laparoscopic resection [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]) should not be denied simply based on age. A comprehensive geriatric assessment may be useful in formulating an appropriate, individualized treatment plan for the elderly patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=see_link\">",
"     \"Comprehensive geriatric assessment for patients with cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific issues surrounding the use of adjuvant chemotherapy in elderly patients are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link\">",
"     \"Adjuvant therapy for resected colon cancer in elderly patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949127\">",
"    <span class=\"h3\">",
"     Management of carcinoma in a polyp",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of colon cancers arise from polyps (adenomas). Benign adenomas, as well as those with severe dysplasia or carcinoma in situ (no evidence of invasive cancer) can be effectively managed by endoscopic removal (polypectomy) alone as long as the resection margins are free of cancer. Endoscopic resection is also a reasonable alternative to radical surgery for selected favorable-risk early stage colon cancers arising in a polyp. The presence of any of the following factors should prompt consideration of radical surgery, as they indicate a higher risk of residual cancer",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nodal metastases (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125359949#H125359949\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Management of carcinoma in a polyp'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Poorly differentiated histology",
"     </li>",
"     <li>",
"      Lymphovascular invasion",
"     </li>",
"     <li>",
"      Cancer at the resection or stalk margin",
"     </li>",
"     <li>",
"      Invasion into the muscularis propria of the bowel wall (T2 lesion)",
"     </li>",
"     <li>",
"      Invasive carcinoma arising in a sessile (flat) polyp with unfavorable features (eg, lower third submucosal penetration, lymphovascular invasion, poorly differentiated)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949004\">",
"    <span class=\"h3\">",
"     Locally advanced primary lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multivisceral resection is an appropriate option for locally advanced (ie, T4 (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    )), potentially resectable primary colon cancers. The surgical approach to locally advanced colon cancer is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125358938#H125358938\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Locally advanced primary lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949018\">",
"    <span class=\"h4\">",
"     Neoadjuvant chemoradiotherapy or chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neoadjuvant (preoperative) chemoradiotherapy rather than initial surgery is a common approach for locally advanced rectal cancer that is supported by data from randomized trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While neoadjuvant chemoradiotherapy might be considered in a patient with locally advanced colon cancer invading into adjacent organs, the data addressing benefit in patients with colon primaries are limited to isolated case reports and two small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. There is no consensus as to which patients, if any, are suitable for this approach. Furthermore, while concurrently administered chemotherapy provides synergistic antitumor activity, it also increases treatment-related toxicity, which may be prohibitive if the radiation treatment volume includes a substantial amount of bowel.",
"   </p>",
"   <p>",
"    In our view, patients with potentially resectable disease should undergo multivisceral resection rather than upfront chemoradiotherapy, if they are surgical candidates. Consensus-based guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    suggest that patients with locally unresectable colon cancer or who are medically inoperable be given chemotherapy for advanced disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The utility of preoperative chemotherapy for patients with locally advanced primary tumors is unclear; this approach is being directly studied in the phase III FOxTROT trial [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949571\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who have undergone potentially curative resection of a colon cancer, the goal of postoperative (adjuvant) chemotherapy is to eradicate micrometastases, thereby reducing the likelihood of disease recurrence, and increasing the cure rate. The benefits of adjuvant chemotherapy have been most clearly demonstrated in patients with stage III (node-positive) disease, who have an approximately 30 percent reduction in the risk of disease recurrence and a 22 to 32 percent reduction in mortality with modern chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most treatments involve a combination of several chemotherapy drugs, which are given intravenously, in a specific order on specific days. For patients with node-positive colon cancer, a six-month course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -containing chemotherapy is generally recommended for most patients, although the benefits of oxaliplatin are controversial in the elderly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H14#H14\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Oxaliplatin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link&amp;anchor=H17#H17\">",
"     \"Adjuvant therapy for resected colon cancer in elderly patients\", section on 'Oxaliplatin-based regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients with resected node-negative (stage II) disease, the benefits of chemotherapy are controversial, as is the relative benefit of an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    as compared to a non-oxaliplatin-based regimen. Treatment decisions must be individualized. Expert guidelines suggest that the risks and estimated benefits of adjuvant chemotherapy be discussed with patients who have resected node-negative colon cancer. Among the issues that need to be taken into consideration when assessing the risk of recurrence and estimated benefit from specific chemotherapy regimens are: the presence of high-risk clinicopathologic features [fewer than 12 nodes in the surgical specimen; T4 or",
"    <span class=\"nowrap\">",
"     perforated/obstructed",
"    </span>",
"    tumor (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ); poorly differentiated histology; lymphovascular or perineural invasion], mismatch repair enzyme (MMR) status, assessment of comorbidities and anticipated life expectancy, and given the relatively good prognosis of stage II disease, the potential risks associated with treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530401#H589530401\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Risk stratification'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530445#H589530445\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Choice of regimen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link&amp;anchor=H2#H2\">",
"     \"Adjuvant therapy for resected colon cancer in elderly patients\", section on 'Challenges specific to the elderly'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H17950071\">",
"     'Side effects'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p>",
"    A web-based tool is available (",
"    <a class=\"external\" href=\"file://www.adjuvantonline.com/\">",
"     Adjuvant! Online",
"    </a>",
"    ) that can aid the clinician in estimating the risk of recurrence and death based on clinicopathologic features, comorbidity, and the relative benefits of specific chemotherapy regimens. Tools such as these can be valuable aids to enhance the decision making process. However, use of this program is not a substitute for clinical judgment, and careful consideration of all relevant patient- and tumor-related factors that may impact the decision to pursue adjuvant therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H16290395#H16290395\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Web-based tools'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, elderly patients gain as much benefit from adjuvant chemotherapy as do younger individuals, although it is used less often in the elderly, and rates of treatment-related toxicity may be higher. Specific issues surrounding the use of adjuvant chemotherapy in elderly patients and the utility of a comprehensive geriatric assessment in formulating an appropriate, individualized treatment plan for the elderly patient are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link\">",
"     \"Adjuvant therapy for resected colon cancer in elderly patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43624?source=see_link\">",
"     \"Comprehensive geriatric assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17950071\">",
"    <span class=\"h3\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemotherapy carries a risk for significant toxicities, including mucositis, emesis, diarrhea, febrile neutropenia, fatigue, hair loss, hand-foot syndrome (a condition in which there is soreness, redness, and peeling of the skin of the palms and soles of the feet), and cardiotoxicity. The frequency and severity of these side effects vary according to the specific drugs used and how they are administered. Fortunately, most of these symptoms are reversible with cessation of chemotherapy, and late and long-term effects are relatively infrequent with the exception of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -related peripheral neuropathy, which may persist. In most modern trials, rates of treatment-related death range from 0.5 to 1 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=see_link&amp;anchor=H3#H3\">",
"     \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\", section on 'Fluorouracil'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36986?source=see_link&amp;anchor=H23#H23\">",
"     \"Cutaneous complications of conventional chemotherapy agents\", section on 'Acral erythema (hand-foot skin reaction)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37242?source=see_link&amp;anchor=H17#H17\">",
"     \"Neurologic complications of platinum-based chemotherapy\", section on 'Cumulative sensory neuropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most commonly used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based regimens are FOLFOX (oxaliplatin plus short-term infusional",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    [FU] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    ) and CAPOX (also called XELOX, oxaliplatin plus oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    ). FOLFOX requires a central venous access catheter and the use of an ambulatory infusion pump. The oxaliplatin component of XELOX can be administered via a peripheral vein, but some patients require administration via a central line due to an infusion-related pain syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=see_link\">",
"     \"Treatment protocols for colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with stage II disease are more often offered a regimen that does not include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    , typically",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    (LV)-modulated FU or single agent oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    . The range of treatment-related toxicity can be illustrated by the following clinical trial data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the X-ACT study, severe toxicities associated with six months of adjuvant treatment with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       capecitabine",
"      </a>",
"      alone included hand-foot syndrome in 17 percent, diarrhea in 11 percent, nausea or vomiting in 3 percent, and stomatitis in 2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H11#H11\">",
"       \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Capecitabine'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36986?source=see_link&amp;anchor=H23#H23\">",
"       \"Cutaneous complications of conventional chemotherapy agents\", section on 'Acral erythema (hand-foot skin reaction)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In the control arm of the MOSAIC trial, which demonstrated the benefit of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      (FOLFOX) in stage III disease, severe (grade 3 or worse) toxicity with short-term infusional FU plus LV consisted of diarrhea (7 percent), neutropenia (5 percent), nausea (2 percent) and stomatitis (2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/12\">",
"       12",
"      </a>",
"      ]. Higher rates of diarrhea,",
"      <span class=\"nowrap\">",
"       nausea/vomiting",
"      </span>",
"      and myelosuppression are usually seen with bolus",
"      <span class=\"nowrap\">",
"       FU/LV",
"      </span>",
"      regimens that do not require central venous access or an ambulatory infusion pump. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H8#H8\">",
"       \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Infusional versus bolus 5-FU'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In the experimental arm of this MOSAIC trial, the addition of oxaliplatin to short-term infusional",
"      <span class=\"nowrap\">",
"       FU/LV",
"      </span>",
"      (the FOLFOX regimen) resulted in severe (grade 3 or worse) neutropenia (43 percent), diarrhea (11 percent), vomiting (6 percent), and stomatitis (3 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/12\">",
"       12",
"      </a>",
"      ]. In addition, grade 3 sensory neuropathy developed in 13 percent during therapy, but was still present at 48 months in fewer than 1 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The substitution of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       capecitabine",
"      </a>",
"      for infusional",
"      <span class=\"nowrap\">",
"       FU/LV",
"      </span>",
"      in combination with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      increases the convenience of treatment but tends to be more toxic than FOLFOX. As an example, in one adjuvant trial, rates of grade 3 or worse toxicity with CAPOX included diarrhea (19 percent), sensory neuropathy (11 percent), neutropenia (9 percent), vomiting (6 percent), hand-foot syndrome (5 percent), and dehydration (3 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/14\">",
"       14",
"      </a>",
"      ]. Rates of severe diarrhea and dehydration were significantly higher in patients over the age of 65.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17949594\">",
"    <span class=\"h2\">",
"     Benefit of postoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative radiation therapy (RT) is not usually considered a routine component of care for completely resected colon cancer. This is in contrast to patients with rectal cancer, in whom effective adjuvant therapy for both transmural and node-positive disease includes RT. Local recurrence is more frequent with rectal cancer due to the local anatomy and the difficulty in obtaining adequate resection margins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=see_link&amp;anchor=H1#H1\">",
"     \"Adjuvant therapy for resected rectal cancer\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Selected patients with colon cancer who are at high risk for local recurrence (ie, positive resection margins, perforation or abscess formation, T4 disease (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    )) might potentially benefit from adjuvant RT. However, there is a paucity of high-quality evidence addressing the role of adjuvant RT (with or without concurrent chemotherapy) in patients with resected locally advanced colon cancer. A single randomized trial failed to show benefit but was closed prior to achieving its accrual goal because of slow accrual.",
"   </p>",
"   <p>",
"    Despite the lack of evidence proving benefit from randomized trials, consensus-based guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    suggest that adjuvant RT be &ldquo;considered&rdquo; for patients with T4 disease with penetration to a fixed structure. Others suggest that RT be considered on a case by case basis for positive resection margins and disease complicated by perforation or abscess formation. This topic is addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H35#H35\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Adjuvant RT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17948926\">",
"    <span class=\"h1\">",
"     METASTATIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 20 percent of newly diagnosed colon cancers are metastatic at presentation. The most common distant metastatic sites are the liver, lungs, and peritoneum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Metastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although major advances in systemic chemotherapy have expanded the therapeutic options for these patients and improved median survival from less than one year to 20 months or longer, fewer than 10 percent of those treated with chemotherapy alone are still alive at five years, and essentially none are free of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21833?source=see_link&amp;anchor=H183911606#H183911606\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: General principles\", section on 'Chemotherapy versus supportive care'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21833?source=see_link\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, surgery provides a potentially curative option for selected patients with limited metastatic disease, predominantly in liver and lung. Long-term survival can be achieved with metastasectomy in as many as 50 percent of cases, and an aggressive surgical approach to both the primary and the metastatic sites is warranted, in conjunction with systemic chemotherapy. The timing of surgical intervention (particularly in patients who present with synchronous metastatic disease) is controversial. Management of potentially resectable hepatic metastases (including a discussion as to integration of systemic chemotherapy into the surgical paradigm) and resection of pulmonary metastases are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Even patients who are not candidates for a curative resection can benefit from surgical palliation for symptoms of obstruction and bleeding from the primary tumor, although the overwhelming majority of patients without symptoms who initiate chemotherapy never require palliative surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=see_link\">",
"     \"Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The various prognostic factors for patients with resected colon cancer are discussed in detail separately, but issues related to general prognosis will be briefly reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Prognostic determinants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most important indicator of outcome following resection of colon cancer is the pathologic stage at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Five-year survival rates according to tumor stage at diagnosis for patients with colon cancer derived from the population-based SEER (Surveillance, Epidemiology and End Results) database and stratified according to the most recent 2010 AJCC staging criteria are illustrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef81414 \" href=\"UTD.htm?40/54/41824\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For individual patients, a postoperative nomogram has been developed that permits a prediction of the risk of a colon cancer recurrence based upon clinicopathologic factors and whether adjuvant chemotherapy was administered or not [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/18\">",
"     18",
"    </a>",
"    ]. The nomogram, which has not yet been independently validated, is available",
"    <a class=\"external\" href=\"file://www.mskcc.org/mskcc/html/5794.cfm\">",
"     online",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In addition, two web-based programs are also available (",
"    <a class=\"external\" href=\"file://www.adjuvantonline.com/\">",
"     Adjuvant! Online",
"    </a>",
"    and",
"    <a class=\"external\" href=\"file://www.mayoclinic.com/calcs\">",
"     Numeracy",
"    </a>",
"    ) that allow the clinician to calculate the estimated risk of disease recurrence and mortality based upon an individual patient&rsquo;s clinicopathologic features, and the relative benefit to be gained by different adjuvant chemotherapy strategies. The derivation and clinical use of these tools is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530438#H589530438\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Summary and recommendations from expert groups'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the available prognostic estimates use five-year survival as the endpoint, given that most recurrences develop within this time frame. In data derived from the 20,800 patient ACCENT database of patients undergoing adjuvant chemotherapy for stage II or III colon cancer, recurrence rates after five years never exceeded 1.5 percent annually, and after eight years, they were 0.5 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result, conditional survival (eg, the survival probability after a given length of survival) improves dramatically after five years. In a study of over 83,000 colon cancer survivors derived from the SEER database, by the fifth year after diagnosis, the five-year disease-specific conditional survival probability was &ge;80 percent for all disease stages except stage IV (48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/20\">",
"     20",
"    </a>",
"    ]. A",
"    <a class=\"external\" href=\"file://www3.mdanderson.org/coloncalculator\">",
"     web-based tool",
"    </a>",
"    is available to determine conditional survival expectancy based upon initial stage at diagnosis, ethnicity, age, gender, and histologic grade.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17950079\">",
"    <span class=\"h1\">",
"     POSTTREATMENT SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following treatment for a stage II or III colon cancer, posttreatment surveillance usually consists of periodic history and physical examination with serial assay of the serum concentrations of the tumor marker carcinoembryonic antigen (CEA), annual surveillance CT scans, and colonoscopy to detect metachronous primaries (",
"    <a class=\"graphic graphic_table graphicRef58912 \" href=\"UTD.htm?20/53/21341\">",
"     table 2",
"    </a>",
"    ). Following treatment for stage I colon cancer, posttreatment surveillance consists only of periodic history and physical examination and colonoscopy. The rationale for and evidence supporting these guidelines are discussed elsewhere, as are issues that arise in long-term survivors of colon cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link\">",
"     \"Surveillance after colorectal cancer resection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28202?source=see_link\">",
"     \"Approach to the long-term survivor of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17950156\">",
"    <span class=\"h1\">",
"     GENETIC ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most colorectal cancers are sporadic, specific genetic disorders have been identified, most of which are autosomal dominant, that are associated with a very high risk of developing the disease. Familial adenomatous polyposis (FAP, 90 percent risk of colorectal cancer by the age of 45 in the absence of prophylactic colectomy ) and Lynch syndrome (hereditary nonpolyposis colorectal cancer (HNPCC), lifetime risk of colorectal cancer 25 to 75 percent) are the most common of the familial colorectal cancer syndromes, but together these two conditions account for only about 5 percent of cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link&amp;anchor=H90629953#H90629953\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\", section on 'Hereditary CRC syndromes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=see_link\">",
"     \"Clinical manifestations and diagnosis of familial adenomatous polyposis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lynch syndrome is more common than FAP and accounts for approximately 2 to 3 percent of all colonic adenocarcinomas. The term Lynch syndrome is now commonly used for families who have been genetically determined to have a disease-causing defect (inherited or de novo) in one of the mismatch repair (MMR) genes. The biologic footprint of a defect in MMR capacity is microsatellite instability (MSI) detected by PCR. MSI testing of colorectal cancers is routinely used to help establish the diagnosis of Lynch syndrome. Some institutions perform MSI testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunohistochemistry (IHC) testing for MMR proteins in colorectal cancers in young patients (diagnosed prior to age 50 years) or in those who meet the Bethesda criteria (",
"    <a class=\"graphic graphic_table graphicRef72965 \" href=\"UTD.htm?41/48/42763\">",
"     table 3",
"    </a>",
"    ). At other institutions, universal testing of all colorectal cancers for MSI is practiced. Although over 90 percent of Lynch syndrome related colorectal cancers will demonstrate MSI, 15 percent of sporadic colorectal cancers have MSI. Thus, the finding of MSI in a colorectal cancer does not indicate Lynch syndrome, but instead identifies those patients who should be referred for germline MMR testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29783?source=see_link\">",
"     \"Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Extracolonic cancers are very common in Lynch syndrome, particularly endometrial carcinomas, which may occur in up to 60 percent of female mutation carriers in some families. Other sites at increased risk of neoplasm formation include the ovary, stomach, small bowel, hepatobiliary system, brain and renal pelvis or ureter. Periodic screening is recommended by expert groups. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29783?source=see_link&amp;anchor=H21758716#H21758716\">",
"     \"Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families\", section on 'Extracolonic tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of one or more of these cancers in a family member of a colon cancer survivor may prompt consideration for genetic testing. Family history is seldom updated regularly during follow-up. However, regularly updating a three-generation family history pedigree from cancer survivors can be valuable to help determine the potential risk for cancer in family members, as well as for the survivor&rsquo;s own risk of subsequent cancers that may be associated with a previously unrecognized hereditary syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF LOCALLY RECURRENT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selected patients with locally recurrent colon cancer can be cured, typically with multimodality therapy. Prognostic factors for outcome in patients with recurrent colon cancer were addressed in a large database series of 17,381 patients who were enrolled in 18 randomized phase III trials testing adjuvant chemotherapy for stage II or III colon cancer conducted mainly before 2000 in the era when treatment was mainly limited to 5-FU [",
"    <a class=\"abstract\" href=\"UTD.htm?29/49/30489/abstract/21\">",
"     21",
"    </a>",
"    ]. The median survival of all patients experiencing a recurrence was 13 months. Survival was significantly better in patients with initial stage II rather than stage III tumors (median 18 versus 13 months), those with a longer disease-free interval, and in those who did not receive 5 FU-based adjuvant chemotherapy following resection of the primary tumor.",
"   </p>",
"   <p>",
"    Although there are no prospective trials to guide therapy, the management of these patients is typically multidisciplinary and may include chemotherapy, chemoradiotherapy, or intraoperative radiation therapy, in addition to surgery. While guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    recommend six months of adjuvant chemotherapy after resection of colorectal cancer liver metastases, they do not address the utility of chemotherapy after resection of a local recurrence. The decision must be individualized, and is based, in part, on whether adjuvant therapy (particularly an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -containing regimen) was administered previously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Systemic chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=see_link\">",
"       \"Patient information: Colectomy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=see_link\">",
"       \"Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The diagnosis of a colon cancer is usually made by colonoscopy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The AJCC 7th Edition TNM staging for colorectal cancer is illustrated in the table (",
"      <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17948751\">",
"       'Staging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pretreatment clinical staging is best accomplished by physical examination, CT scan of the abdomen and pelvis, and chest imaging. Serum levels of the tumor marker carcinoembryonic antigen (CEA) should be obtained preoperatively in most patients. (See",
"      <a class=\"local\" href=\"#H17949425\">",
"       'Radiographic imaging'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17949195\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ideally, each patient should have a colonoscopic examination of the entire colon prior to surgery. If full colonoscopy cannot be performed because of obstruction or poor preparation, CT or MR colonography can be done, or alternatively, the entire residual colon should be examined colonoscopically soon after resection. (See",
"      <a class=\"local\" href=\"#H17949202\">",
"       'Colonoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A family history of colorectal and other extracolonic cancers should be sought prior to therapy, as an inherited predisposition to colon cancer may alter the surgical approach, prompting consideration of subtotal or total colectomy in high-risk individuals. (See",
"      <a class=\"local\" href=\"#H17949245\">",
"       'Family history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical resection is the only curative modality for localized colon cancer. Endoscopic resection is a reasonable alternative to radical surgery for selected early stage colon cancers arising in a polyp, as long as they meet certain criteria for favorable risk. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Surgical resection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17949127\">",
"       'Management of carcinoma in a polyp'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      For patients who have undergone potentially curative resection of a colon cancer, postoperative (adjuvant) chemotherapy eradicates micrometastases, reduces the likelihood of disease recurrence, and increases cure rates. The benefits have been most clearly demonstrated in patients with stage III (node-positive) disease. In this setting, a six-month course of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      -based chemotherapy is generally recommended. The benefit of chemotherapy for resected stage II disease is controversial, and treatment decisions must be individualized. &nbsp;(See",
"      <a class=\"local\" href=\"#H17949571\">",
"       'Adjuvant chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chemotherapy carries a risk for significant toxicities, including mucositis, emesis, diarrhea, febrile neutropenia, fatigue, hair loss, hand-foot syndrome, and cardiotoxicity. The frequency and severity of these side effects vary according to the specific drugs used and how they are administered. Fortunately, most are reversible when chemotherapy is discontinued. (See",
"      <a class=\"local\" href=\"#H17950071\">",
"       'Side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients who present with metastatic disease are not surgical candidates, and palliative chemotherapy is generally recommended. However, surgery may provide a potentially curative option for selected patients with limited metastatic disease, predominantly in liver and lung. An aggressive surgical approach to both the primary and the metastatic sites is warranted in such patients, in conjunction with systemic chemotherapy. For patients with unresectable distant metastases, the overwhelming majority of patients without symptoms who initiate chemotherapy never require palliative surgery. (See",
"      <a class=\"local\" href=\"#H17948926\">",
"       'Metastatic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important indicator of outcome following resection of colon cancer is pathologic stage (",
"      <a class=\"graphic graphic_figure graphicRef81414 \" href=\"UTD.htm?40/54/41824\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Prognosis'",
"      </a>",
"      above.) Following treatment for a stage II or III colon cancer, posttreatment surveillance usually consists of periodic history and physical examination and assay of the serum CEA, annual surveillance CT scans, and periodic colonoscopy (",
"      <a class=\"graphic graphic_table graphicRef58912 \" href=\"UTD.htm?20/53/21341\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Following treatment for stage I colorectal cancer, posttreatment surveillance consists only of periodic history and physical examination and colonoscopy. (See",
"      <a class=\"local\" href=\"#H17950079\">",
"       'Posttreatment surveillance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regularly updating a three-generation family history pedigree from cancer survivors can be valuable to help determine the potential risk for cancer in family members, as well as for the survivor&rsquo;s own risk of subsequent cancers that may be associated with a previously unrecognized hereditary syndrome. (See",
"      <a class=\"local\" href=\"#H17950156\">",
"       'Genetic issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Selected patients with locally recurrent colon cancer can be cured, typically with multimodality therapy. (See",
"      <a class=\"local\" href=\"#H37\">",
"       'Management of locally recurrent disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/1\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/2\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/3\">",
"      Chautard J, Alves A, Zalinski S, et al. Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients. J Am Coll Surg 2008; 206:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/4\">",
"      Frasson M, Braga M, Vignali A, et al. Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum 2008; 51:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/5\">",
"      Yoh T, Yamamichi K, Oishi M, et al. [A case of effective neoadjuvant chemoradiotherapy with capecitabine for locally advanced sigmoid colon cancer]. Gan To Kagaku Ryoho 2011; 38:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/6\">",
"      Kuga Y, Tanaka T, Arita M, et al. [A case of effective chemotherapy using S-1 and CPT-11 following chemoradiotherapy with UFT and Leucovorin for unresectable advanced sigmoid colon cancer]. Gan To Kagaku Ryoho 2010; 37:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/7\">",
"      Mizukami H, Yoshizawa Y, Sasaya S, et al. [A case of advanced colon cancer invading the rectum effectively treated with chemoradiation therapy before surgery]. Gan To Kagaku Ryoho 2007; 34:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/8\">",
"      Cukier M, Smith AJ, Milot L, et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experience. Eur J Surg Oncol 2012; 38:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/9\">",
"      Taylor WE, Donohue JH, Gunderson LL, et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol 2002; 9:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/10\">",
"      . Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012; 13:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/11\">",
"      Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005; 352:2696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/12\">",
"      Andr&eacute; T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350:2343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/13\">",
"      Andr&eacute; T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27:3109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/14\">",
"      Schmoll HJ, Cartwright T, Tabernero J, et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol 2007; 25:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/15\">",
"      Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009; 27:3379.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition, Edge, SB, Byrd, DR, Compton, CC, et al (Eds) (Eds), Springer, New York 2010. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/17\">",
"      O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/18\">",
"      Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008; 26:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/19\">",
"      Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009; 27:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/20\">",
"      Chang GJ, Hu CY, Eng C, et al. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 2009; 27:5938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/49/30489/abstract/21\">",
"      O'Connell MJ, Campbell ME, Goldberg RM, et al. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol 2008; 26:2336.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2507 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-53F9A3D73A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30489=[""].join("\n");
var outline_f29_49_30489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17948751\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17949181\">",
"      THE CLINICAL STAGING EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949425\">",
"      Radiographic imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949195\">",
"      Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949202\">",
"      Colonoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949245\">",
"      Family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17948781\">",
"      MANAGEMENT OF LOCALIZED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Surgical resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7619375\">",
"      - Elderly patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17949127\">",
"      - Management of carcinoma in a polyp",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17949004\">",
"      - Locally advanced primary lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H17949018\">",
"      Neoadjuvant chemoradiotherapy or chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949571\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17950071\">",
"      - Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17949594\">",
"      Benefit of postoperative RT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17948926\">",
"      METASTATIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17950079\">",
"      POSTTREATMENT SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17950156\">",
"      GENETIC ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      MANAGEMENT OF LOCALLY RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2507\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2507|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/22/13670\" title=\"figure 1\">",
"      Arterial circulation to the large bowel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/54/41824\" title=\"figure 2\">",
"      SEER surv adeno colon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2507|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/26/23982\" title=\"table 1\">",
"      2010 TNM staging colorectal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/53/21341\" title=\"table 2\">",
"      Postop surv ASCO NCCN rec",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/48/42763\" title=\"table 3\">",
"      Revised Bethesda criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=related_link\">",
"      Adjuvant chemotherapy for resected stage II colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=related_link\">",
"      Adjuvant therapy for resected colon cancer in elderly patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=related_link\">",
"      Adjuvant therapy for resected rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=related_link\">",
"      Adjuvant therapy for resected stage III (node-positive) colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28202?source=related_link\">",
"      Approach to the long-term survivor of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=related_link\">",
"      Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17016?source=related_link\">",
"      Clinical manifestations and diagnosis of familial adenomatous polyposis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43624?source=related_link\">",
"      Comprehensive geriatric assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=related_link\">",
"      Comprehensive geriatric assessment for patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36986?source=related_link\">",
"      Cutaneous complications of conventional chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=related_link\">",
"      Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=related_link\">",
"      Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29783?source=related_link\">",
"      Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=related_link\">",
"      Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37242?source=related_link\">",
"      Neurologic complications of platinum-based chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=related_link\">",
"      Pathology and prognostic determinants of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=related_link\">",
"      Patient information: Colectomy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=related_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=related_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=related_link\">",
"      Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=related_link\">",
"      Surgical oncologic principles for the resection of colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=related_link\">",
"      Surveillance after colorectal cancer resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21833?source=related_link\">",
"      Systemic chemotherapy for metastatic colorectal cancer: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=related_link\">",
"      Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=related_link\">",
"      Treatment protocols for colorectal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_49_30490="MRI urethral diverticulum1";
var content_f29_49_30490=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82937%7EOBGYN%2F82938%7EOBGYN%2F82939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82937%7EOBGYN%2F82938%7EOBGYN%2F82939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image of female urethral diverticulum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T2 axial contrast enhanced MR image shows a diverticulum (arrows) wrapped around the urethra.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image of female urethral diverticulum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T2 coronal contrast enhanced MR image shows a diverticulum (arrow) wrapped around the urethra.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image of female urethral diverticulum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T1 axial contrast enhanced MR images shows a diverticulum (arrows) wrapped around the urethra.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30490=[""].join("\n");
var outline_f29_49_30490=null;
var title_f29_49_30491="HRV parameter values MI";
var content_f29_49_30491=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Optimal cutpoints for predication of all-cause mortality after myocardial infarction by frequency domain measures of heart period variability",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Optimal",
"cutpoints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        At discharge two weeks after MI",
"       </td>",
"       <td class=\"subtitle2\">",
"        After recovery from MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ultra low frequency power (ms2)",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        5000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Very low frequency power (ms2)",
"       </td>",
"       <td>",
"        180",
"       </td>",
"       <td>",
"        600",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low frequency power (ms2)",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High frequency power (ms2)",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total power (ms2)",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        6000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low frequency/high frequency ratio",
"       </td>",
"       <td>",
"        0.95",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MI: myocardial infarction.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bigger JT Jr. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology From Cell to Bedside, 2d ed, WB Saunders, Philadelphia, 1995, pp. 1151-70.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30491=[""].join("\n");
var outline_f29_49_30491=null;
var title_f29_49_30492="Diff dx elevated IgE";
var content_f29_49_30492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F83457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F83457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with elevated serum IgE",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td rowspan=\"8\">",
"        <strong>",
"         Infectious diseases",
"        </strong>",
"       </td>",
"       <td rowspan=\"3\">",
"        Parasitic",
"       </td>",
"       <td>",
"        Ascariasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schistosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strongyloidiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        HIV infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        <em>",
"         Mycobaterium tuberculosis",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Cytomegalovirus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        EBV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Candidiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        <strong>",
"         Atopic diseases",
"        </strong>",
"       </td>",
"       <td colspan=\"2\">",
"        ABPA (Allergic bronchopulmonary aspergillosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Allergic fungal sinusitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Atopic dermatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Allergic asthma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Allergic rhinitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        <strong>",
"         Immunodeficiencies",
"        </strong>",
"       </td>",
"       <td colspan=\"2\">",
"        Hyper-IgE syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Wiskott-Aldrich syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Netherton's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        IPEX (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Omenn syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Atypical complete DiGeorge syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         Inflammatory diseases",
"        </strong>",
"       </td>",
"       <td colspan=\"2\">",
"        Churg-Strauss vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Kimura disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         Neoplasms",
"        </strong>",
"       </td>",
"       <td colspan=\"2\">",
"        Hodgkin's lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        IgE myeloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        <strong>",
"         Others",
"        </strong>",
"       </td>",
"       <td colspan=\"2\">",
"        Tobacco smokers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Cystic fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Nephrotic syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Bullous pemphigoid",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30492=[""].join("\n");
var outline_f29_49_30492=null;
var title_f29_49_30493="Genetic mutations survival I";
var content_f29_49_30493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Survival in hypertrophic cardiomyopathy is related to the genetic defect",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 377px; background-image: url(data:image/gif;base64,R0lGODlhQAF5AeYAAP///wAAAP8AAAAz/6qqqgBmMzMzM3d3d4iIiO7u7hEREVVVVSIiIkCMZkRERN3d3WZmZmCA/8zMzODm/4CzmcDZzSB5Tbu7u/D282CggKDGsxFwQZmZmdDj2ZC8prDQwIig/+Ds5v9VVe718RBwQP+IiDCDWf8REf/MzFCWc3CpjVV3//+qqneS/xFB/zOFXDNc//93d4i4oKq7/yJO//+AgJmt/3etkszW/93k/yJ6Tu7x//9AQMzg1v/AwESPaf8QEP/Q0P8iIv/u7v+QkP+goP9QUP9gYGaF/5nCrarMu/8zM//w8P8wMERp///g4P+wsP8gIFWZd/9wcN3r5P9ERP/d3bvWyWajhf+ZmfDz/7vJ//9mZu8GA285HM8JL++zwA8v789Jb38Zf+4jMODW7wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABAAXkBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/DxDgESggnzAQ4PggcBAQwE4glMRsAfPUELAhCQEMAAAAQBDgBgoCDBwIvGEtYDoCCAxY4JEgYUibGkMI0AEgRQIAikgYMkEWGApMWkzVEoOXrUGVIhgJgADBos4KWLgKNIkypdyrSp06VMbl7MKfJCw4cRE1C0eChAiBQkPDSaEGFAhAmfmkCRGq+gwQUp//Hp4+cPYKIAgiqYsPBhbNmznWpMYUs4Et5BGiw0qODXLFpNPpoUntzo8CAMFEhkCNEYcCYBUSmL7noIQwYSFGYyIusYE48io2MTsmyoQwMSGhyx9kypxhHZwGkfqmDBAuPOjyUFiQJctnBEGkg04Ix8EpAnzUc/l0mhQAbVq/8md2QEdnbK2xOFOJ1at/hHRH6fn5xeUYUGFnK7b80oCJD59FHygWLHVbcIEEEASFh9jWSWAnUGInIEEQqyxWAjGKhQAIQRFlKEERVKdaEjKegHyW7jCfLEfyHaNGIjHqRACYqFRJFgiyW9yEgIBVhCoyBH1IBjjpqY0JeP7xXBw/+QGOnIiAcZZLJbGQIweZGTi3RAwiasfQGGlQJhuQhfnEwgxhi8gcmOmIqooEInUJDxnprrsJlIBxZ0wsRTfDpFpzR2JmJBB6H8KImN1bQwAAgtBopIBm+KYugjPKzVzAoDZLooAIoyqoiimsIwCAibAoADDZnSYIMgOTiRqQs5mOPoIR+YUMqkjNQg5KUDzACAqzN0uoiiLRCyg6aeglBsDi64AMAONLjg6wwryNoJCRxKOicjRIDIq6+dKuqECwNUCwCpmTIK6gAw4DBqqYMwK6oNAyBBCKnVkgoCDjBo6i42sx6SgVin4HqID0t+C0C/OAhLLg6kFotqrILQS8P/u54KQu4Aqwo7yA7NQutsv6tuE7AhGtiaCmuatuxyGAK4LPPMNNds8802M4Jpqh1vyvDOmvoqyLHOCqKvIROTai8hmGJaLL2ZwrBDNicXgsGGq9TEyHUKDyIsw0oz7Su95p5bKhKMQjtADiJPWy0OmlIsCMlUe1JiLjz40LUgXw/gLrqZNqzpClMfq6mzUA+gKquuDgDr3OVqrOnSAHuigYy4TChav1uEU7XVBYBXi2CUbcGuOJ8XYoKJtSD85zOpEwIlLv697kzsg4SwJS5V2s4M7oMYiUsTevuuDPCCqBDlLeUZfzwoWuKiq/PJIC/IoLd8SD0y1gPg5i2RbX9M//fE8S6+Md0DQAKhtiB4PjHpD3xL3u8Pk36tt0yxa/3ApA8A1rWID/+C4b8UEIwWrhvgL/yngQbYYkUKXOAornYL0ESwF/4DAPZqQT9oxEAAJQAFCgQgAgCc4ATnyGADjkQLI1AoGSJISgg/GEJGVEEAKCBECUA4iA8KQAgsAMAIS3jCaEgAH3YBQD/+ERBEZFAFFLDF9GAogCDekAU0XAQLkJJDAAwBKTXcYQwAIIQTDGGIJkQhNBhAjwesBCsS2YoTSTG7WkAhYciIYRBp+MEqnICEgtjhUWoIgBh2MZA8LGQVFckCNBZxCDH8YRCTkRAHQAQCP/EJUAqRwfvYYv85ytAjAJaAwyz+EQViJKMArCAIQ+owkaTMoR4diUI9WuGHymBIXTgAgJfUY5OzIYXuKtinYhrzmMY0RCR/mAUAZDGWyzzKJF05iB3WUJSzBGQR/5iUISSDIgAgQEceQBKgCMUfpejRaETZQx7GcodcUCYOXxlGAcRgCGU8ozZrKYBmMkMBCtgHGx8AkQNopSJzJIUJCjQZdgrimfMU5FFQsEWklPCLSFGjD4EoxH16cZlqRAYBXtKQJi4xiaQhRQNYd8F3ZBAAFIhiS+Px0svNlKal8ORNXVoKCu7UHS/9n+h+mo6gLoaoazKFAZHqiwvsAwBOPUVQY8rUXhhAIkr/dIgpgvoBB1Y1FxcwgAIYYACxarUUQdXLV3PhFoMogJdbPYU613qLBEAAAQngilRPgS264iIBCDiAYBGwV1Mc1a+2wIc/zkqKoAIgAzJF7CxUYgACWPYChS0FBSIl2VlcdRWO1WlnZQEBBgj2AISNqynwNFrPCoWxo3Asj1jaWlZcAAGWtWxmS6GBAtC2tqmAiEIMgEnVnqK3vwWuKcgKkAPAVhSORYxvlasKlYyUABB4biiiK93kUjcUDMjuARRQXLSyArnfPQUH3PpU8553uuktxQVQ2173vjdb8fXEARwAAAkYAK72ZcVC8ysKBaR2AdoFBXcNIT8Cf8K6/Ejw/ycWXAgKLM/BnigrBzhA3t2uQrQY5sR6/RFQD6vCpyHuhAToiwoKF2KDKdYEBMrbYljcLcaaQDBoYbFZHGsCAQo4bWoDzIqu+jgTJF2siVUxzCNf4gK5JQBmjeuKvjrZEg8gQAK0vGRVrPDKlRDuSGkc21hQFcyTYC4BnNvlVDQQzZKwbmWz22ZUsBbOkQjvVTtMZVeEDs+QGPFK6lvmWBwW0I6YLwIIXWhYQBHRj+AAi+uMihhBuhEQcOtGiNwKtV5aESpZAAE4zN8++7kAqE61qlE9VDRXNsKUpsWXEQ0BBwjWAbYeMnR/UUdAJ9kgEuaEiydxZ0BDOcpS5rQuYP/86VjTosHNdvYsjBxtSXCApFg9aRNT6ourtbraiigIXAZR0IkglNu+mDWiCSDqSMyDjW/N5Eh8gu5e9NrY/nDAphkBkgcAtJcwobchhk2JYiN6y6h9xEABLoFyCvycBKcEs4982orruhH9WPRY4XhQvXJSGNA+skogHmxEJCQfG9H2XYRB7Ssj+7LSpoW3AZ1Xjzd2GOq+MpCBHXNa3NvJDGCjWMetbF4YXOQBgIhdiX7zYUwcx3I+gI5N7YuQH9kAC1gimXc9jJY7+akIuHijgzHzK5d10amIuCVy7uNM+6PdVPfFz338gGtfJe69ODqOL1Dat/fcFk9P8UvCO2X/vPfC6jFGAIBrXAyvg1vYxih7jA9AUIv/3RZsd7CcX3v5Wsx9ECPYQAF+4IgRrPoFghiBDjYwCCr8ANU/GIESVl2AHgxJyxyIcuGbXgy9D0IGqaZCJKRQgBsA4AaoZr0gXlCAKyShAFJIfQGUD6azM3rsxAg8AJjPfOObfgOvHwHwp1/8QfSgADogxAaU/31BrF/67J9++KfPfB0IvzluDwDciw4MxAPg/DoAgABgeqkmgMBnfMtXADKgftSnA7UHAO83gNMnfanWfs9HetlRdy9RcpB3DI4nCFiwakrQfgAAfNF3gIIwe6jHgIOgBKLngOkngfE3g/9XACsIHHzH/0b613m1gGLq94DAF3sTCABXYIMlWH4A4IBKUAgRSAghmATwF4UyeITR1xyDBwG7x3vGMGCEAHwrGHq1N4THh2rdd4Q3OIaptoDj9wJQKIUk+H2iF3vZoXg7hgyQZQmv14afQILzMWN1eAw2JQnMh2oICAp8eB5Tl3bJ4HsEBmRCxoO2AECCx3mGBwyZR2DHBnOV+AtnlmKB9Yib6AsfSGC/xoGboHaawCN7l1sGBomAxz4+ZgClxn/CcGMh9omZZoqagIqaYGEx9muLh33G4GmXkV+ZuG9aiAy0J4nUFXb3wHTJ2AwZcGHUxQAIcHJit13SwCP4NVpyRly6mAm8GP8KvvhdQRYRbBaKkbc+3+V2IwWNXCcNFOBVygVYHJAAB4CM8RgNGEACDPV4jDCOojCPAPkIAhkK/fiPBZlQ1ECQypVlW2Zz+zgNxgFcYkZcrhgMKQNcapaOtOgM+dFacoZd4YgJBzkKiVFbejZeW6eN2BCSoyVoJaaOy5CSraVo19cIVkFvKseQ17A6o5WTj/AAFOET5SZH9VYN5dNZ1kcJWOdw87ZtH6cNDRBZfpV/++cIDuAQJOFL8uaT11ABJPBtVaWBd+cIuiQU7KZJD3dO3FCVkpWDfjcJJFFQHQeWYTmWiHWFWQgJMdGTSXkNcOlXdKgKJ3kKWkKWN0V5nzj/WBl5DHdYVZvHczT5DNz4VVqWiclWmc8wjXQVVVAllJ5wmKhwmV/1WVn1mMggPEwVVmNVVgpQkpdAmqjwaEzVViQWjBO5DaN4U3aFVxIpjNrgg5KZV4z3DVzIVDunZJwJDbbJVEHXEAoAjy75Db3ZUiqhdBBAnQoWDqrIVFGXiNHIDRXJVFindaqZDJH5VWF3nN8QiD9VcaD4kdfQZDs1cuckm5ZAm6qgfQr0cptJn9fgfy3VmAnXnNEAnz9Vium5iLtDVJnYiggaDex4mrM4nt2wVESFi2eJodzweRcEjA26iHkCobmlj7v5DVZWbfy5CrZ4UwSwlWXVkt1JDiCq/0AdQZkCig1LuVPkVXPuKQ7MWKAOkFt9WZ3jsFI/lX8dKpzf0GO+2RDz6aHdQIwz5QA06qTf8Gc3tQCxOaMjugyXOEAMOqHTAKW+CaRhqgxWekEGmo01Wg6SF6KUuKNUyUIXFKFwOmHocKMKJItrqgyMWD8cqp+V0KKu4J/nI6JmSg0E+j7HGKTkcJ3bM1JwdW1SqaXgMKf146WEMJ2BKqZ4Wj9lRQil2qjU4KfOI1ZckQCxGaqCWqIDBBGmdQBstKejuQ6K6jxMeqFUGg6Puj3zdQC6qanhQKlHhqivwKmjJQE5OhdKVBeZGkzrMKaI1Z4FwV9HeW4Dxw6qiljrxf+VbDmtgqCsrzCokiVOScdwXxmY5rCra+V24waVgwBx7RCsa3VyWMVxSNmt7ICsX3VyBlEPgOmv60CcYGausACvIaawr2CtOOawrvCcaCaxrfCtDesOIJaw7mCfFfsOc/Wx7pCcHOsOSgpnFtsKnViy7aCgV5ayrLCxTgazq4CwyQoPXMqy7XBoLwsPGqqz7LCyMwsPAOtgNPthKgO07BCyQwsPK9q078CzNwsP6wm17oCmVtsOMhux8YCuGHa0rMC0Pga2q5CzUwsPUsu18ZC2MUa2qoCvBOa2qSC0agsPWDu2ArG1KSa3qKC3Gdu1snq2OKu07SC2bTsQJFu3aKv/kHs7EC+quO9At40rEJL7t/Hgsoebt/SIt3mbtJwrEIZrufEQul97EQz7XXybCmxbugOxukZ7ERSbuZRrlbIbDxhbVQU7lZqrXNsanEFxEX5LV/Tqruxgs3sZcOT6uxdBusI7rk4EcdAbvdI7vdRbvdZ7vdibvdq7vdzbvdyrDXbZr63gWEFFvoZ5DrnLCuZrpyZ5vtuzvr/agZJqO/BrrPILqwuCv9TKvru4kP77vwAcwAI8wARcwAZ8wAicwMbAYf6Aq5XgrPm2D/cQwZ2wkwExwfkgmpFgdxERFxSsCUckrR6cwZwAEUPGwOsKACjswN7AEOKavJaArfkgby7M/wlE2RFRWcOZIG6EIBI6nAlsJAFuxBI+3KSVgJ+pVcNF/MLoUG7lBgrhyhNSrAlP6RMgMcWX8G4rwUtXfMWZUEmXJMVenAkmLAhOHBFnvK/lkHFwBArqildvhMVZ/MIqwRJyXAn9BlB13BI7kQlpyQD3GMdjjAllHK2EVVBs/MTmkMafIK98/BF9fAlpaRDqCsm+m2cBsA++1MWRfAngpK7+thODfAmFnMaMfA41PA8wXAn6OghVYcSYAJVWYaiHkHH+xgDyNsubAFAClcmvTMuIUMiprBDDvMrfsMKfILD+IAEYDK2cQBLNrMF+mW/1EM2bMFKLdcFyIc2OgJ9xjKvMKpyjLKzA5FzO5nzO6JzO6rzO7NzOIaIVRgnL7vwL68UARBkARzrPvzAPHVFcwrWu/2wXLyESS7SD+swKocwAFnGUmUxuM5xkBQHMB70JmXZg52RZiuUQXonBKTzRqsDGWEFjHXEBNeyVg1AQuOzRH93R/0wPwrWB7PrPr6bSNF3TNn3TOJ3TOr3TPN3TPv3TQB3UQj3URF3URn3USJ3USr3UTN3UTq0ggQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Individuals with the Phe110Ile mutation in the troponin T gene have a good prognosis that is comparable to that of patients with the benign Phe513Cys mutation of the beta-cardiac myosin heavy chain gene. The survival of patients with the Arg719Trp mutation of the beta-cardiac myosin heavy chain gene is significantly lower (p = 0.0002).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Anan, R, Shono, H, Kisanuki, A, et al, Circulation 1998; 98:391.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30493=[""].join("\n");
var outline_f29_49_30493=null;
var title_f29_49_30494="Ganglion on wrist PI";
var content_f29_49_30494=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ganglion on the back of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 313px; height: 212px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ganglion cysts (see arrow) often form on the wrist. Cysts like these are filled with a clear, jelly-like fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sheon RP, Moskowitz RW, Goldberg VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30494=[""].join("\n");
var outline_f29_49_30494=null;
var title_f29_49_30495="IL17a expression";
var content_f29_49_30495=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F64269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F64269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Defective IL-17a expression in hyper IgE syndrome (HIES)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood mononuclear cells (PBMCs) from a healthy individual and an individual with HIES are stimulated to induce IL-17a expression. IL-17 is severely reduced in patients with HIES.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_49_30495=[""].join("\n");
var outline_f29_49_30495=null;
